pathway |
organism |
UDP-glucose conversion |
Saccharomyces cerevisiae |
Translation factors |
Caenorhabditis elegans |
Principal pathways of carbon metabolism |
Saccharomyces cerevisiae |
Colanic acid building blocks biosynthesis |
Saccharomyces cerevisiae |
mRNA processing |
Caenorhabditis elegans |
Fatty acid beta-oxidation 1 |
Caenorhabditis elegans |
Homocysteine and cysteine interconversion |
Saccharomyces cerevisiae |
Cholesterol biosynthesis |
Saccharomyces cerevisiae |
Fatty acid biosynthesis, initial steps |
Saccharomyces cerevisiae |
DNA replication |
Saccharomyces cerevisiae |
Neurotransmitter release in cholinergic motor neurons |
Caenorhabditis elegans |
Cell division: first embryonic mitosis |
Caenorhabditis elegans |
Vulval development |
Caenorhabditis elegans |
TOR signaling |
Caenorhabditis elegans |
Fatty acid beta-oxidation 2 |
Caenorhabditis elegans |
Sucrose biosynthesis |
Saccharomyces cerevisiae |
Aspartate biosynthesis |
Saccharomyces cerevisiae |
Metapathway signal transduction |
Caenorhabditis elegans |
Gluconeogenesis |
Saccharomyces cerevisiae |
Proteasome degradation |
Saccharomyces cerevisiae |
UDP-N-acetylgalactosamine biosynthesis |
Saccharomyces cerevisiae |
Tryptophan biosynthesis |
Saccharomyces cerevisiae |
Fatty acid elongation, unsaturated |
Saccharomyces cerevisiae |
NAD salvage pathway |
Saccharomyces cerevisiae |
Mechanosensory inputs influence pharyngeal activity via ivermectin sensitivity genes |
Caenorhabditis elegans |
Isoleucine degradation |
Saccharomyces cerevisiae |
daf-2 or insulin signaling pathway |
Caenorhabditis elegans |
Leucine biosynthesis |
Saccharomyces cerevisiae |
P-cymene degradation |
Saccharomyces cerevisiae |
Glutamate biosynthesis superpathway |
Saccharomyces cerevisiae |
DNA replication |
Caenorhabditis elegans |
Phenylalanine biosynthesis |
Saccharomyces cerevisiae |
Glutathione biosynthesis |
Saccharomyces cerevisiae |
Isoleucine, leucine, and valine biosynthesis |
Saccharomyces cerevisiae |
De novo biosynthesis of purine nucleotides |
Saccharomyces cerevisiae |
Fatty acid beta-oxidation meta-pathway |
Caenorhabditis elegans |
Cytoplasmic ribosomal proteins |
Saccharomyces cerevisiae |
Triacylglyceride synthesis |
Caenorhabditis elegans |
Pyruvate dehydrogenase pathway |
Saccharomyces cerevisiae |
Serine and glycine biosynthesis |
Saccharomyces cerevisiae |
Cytoplasmic tRNA synthetases |
Saccharomyces cerevisiae |
Ribose and deoxyribose phosphate metabolism |
Saccharomyces cerevisiae |
Notch signaling in vulval development |
Caenorhabditis elegans |
EGF signaling in vulval development |
Caenorhabditis elegans |
Wnt signaling in cell polarity |
Caenorhabditis elegans |
Ascaroside biosynthesis |
Caenorhabditis elegans |
Cell engulfment |
Caenorhabditis elegans |
Heterochronic gene regulation of development |
Caenorhabditis elegans |
Left-right asymmetry in the nervous system |
Caenorhabditis elegans |
Programmed cell death and cell engulfment |
Caenorhabditis elegans |
Immune responses in the epidermis |
Caenorhabditis elegans |
Regulation of immune response in the intestine |
Caenorhabditis elegans |
Sulfide oxidation pathway |
Caenorhabditis elegans |
Aerobic glycerol catabolism |
Saccharomyces cerevisiae |
Male mating |
Caenorhabditis elegans |
Deoxyribose phosphate metabolism |
Saccharomyces cerevisiae |
Biosynthesis and regulation of nematode bile acids |
Caenorhabditis elegans |
Aging |
Caenorhabditis elegans |
Heterchronic control of molting |
Caenorhabditis elegans |
Wnt signaling |
Caenorhabditis elegans |
Glycolysis |
Saccharomyces cerevisiae |
RTK/Ras/MAPK - LET-23, EGL-15 independent |
Caenorhabditis elegans |
Cysteine biosynthesis from homoserine |
Saccharomyces cerevisiae |
ER stress-unfolded protein response (UPRer) |
Caenorhabditis elegans |
Starch and cellulose biosynthesis |
Saccharomyces cerevisiae |
Glucose-1-phosphate metabolism |
Saccharomyces cerevisiae |
Glycine biosynthesis |
Saccharomyces cerevisiae |
ABA biosynthesis |
Solanum lycopersicum |
Gibberellin A12 biosynthesis |
Solanum lycopersicum |
Gluconeogenesis |
Solanum lycopersicum |
Superpathway of pyridoxal 5'-phosphate biosynthesis and salvage |
Solanum lycopersicum |
Pto kinase mediated signaling pathway leading to the oxidative burst in tomato |
Solanum lycopersicum |
Acetylcholine synthesis |
Caenorhabditis elegans |
Triglyceride biosynthesis |
Saccharomyces cerevisiae |
Arginine biosynthesis |
Saccharomyces cerevisiae |
Phenylalanine, tyrosine, and tryptophan biosynthesis |
Saccharomyces cerevisiae |
Carbon monoxide dehydrogenase pathway |
Saccharomyces cerevisiae |
Nutrient control of ribosomal gene expression |
Saccharomyces cerevisiae |
Upiquinone Q prenylation |
Saccharomyces cerevisiae |
Wnt signaling - Q neuroblast migration |
Caenorhabditis elegans |
Polyamine biosynthesis |
Saccharomyces cerevisiae |
Role of lipid metabolism |
Caenorhabditis elegans |
Sex determination |
Caenorhabditis elegans |
TCA cycle - detailed |
Saccharomyces cerevisiae |
Valine biosynthesis |
Saccharomyces cerevisiae |
Tryptophan degradation |
Saccharomyces cerevisiae |
Pentose phosphate pathway |
Caenorhabditis elegans |
Nucleotide metabolism |
Saccharomyces cerevisiae |
Allantoin degradation |
Saccharomyces cerevisiae |
Translation factors |
Saccharomyces cerevisiae |
Threonine biosynthesis |
Saccharomyces cerevisiae |
RuMP cycle, oxidative branch of the pentose phosphate pathway and formaldehyde assimilation |
Saccharomyces cerevisiae |
Glycine degradation |
Saccharomyces cerevisiae |
Protein modifications |
Saccharomyces cerevisiae |
Leucine degradation |
Saccharomyces cerevisiae |
Isoleucine and valine biosynthesis |
Saccharomyces cerevisiae |
Xylulose-monophosphate cycle |
Saccharomyces cerevisiae |
Turbo design of glycolysis |
Saccharomyces cerevisiae |
Crystal toxin triggered necrosis pathway |
Caenorhabditis elegans |
Programmed cell death |
Caenorhabditis elegans |
Pentose phosphate pathway |
Saccharomyces cerevisiae |
De novo biosynthesis of pyrimidine deoxyribonucleotides |
Saccharomyces cerevisiae |
Sphingolipid metabolism |
Saccharomyces cerevisiae |
Meiotic recombination genes |
Saccharomyces cerevisiae |
Pentose pathway, non-oxidative branch |
Saccharomyces cerevisiae |
Fatty acid elongation, saturated |
Saccharomyces cerevisiae |
Riboflavin, FMN, and FAD biosynthesis |
Saccharomyces cerevisiae |
Fatty acid biosynthesis |
Caenorhabditis elegans |
Serine-isocitrate lyase pathway |
Saccharomyces cerevisiae |
RNA interference and miRNA |
Caenorhabditis elegans |
Copper homeostasis |
Caenorhabditis elegans |
Trehalose anabolism |
Saccharomyces cerevisiae |
Cell cycle and cell division |
Saccharomyces cerevisiae |
Poly(glycerol phosphate) wall teichoic acid biosynthesis |
Saccharomyces cerevisiae |
Histidine, purine, and pyrimidine superpathway |
Saccharomyces cerevisiae |
Sulfate assimilation and copper detoxification |
Saccharomyces cerevisiae |
Threonine and methionine biosynthesis |
Saccharomyces cerevisiae |
Eukaryotic transcription initiation |
Saccharomyces cerevisiae |
Ketone bodies synthesis and degradation |
Caenorhabditis elegans |
Asparagine degradation |
Saccharomyces cerevisiae |
Glycogen metabolism |
Caenorhabditis elegans |
Mitochondrial long chain fatty acid beta-oxidation |
Caenorhabditis elegans |
Tryptophan degradation via kynurenine |
Saccharomyces cerevisiae |
Serine biosynthesis |
Saccharomyces cerevisiae |
Pantothenate and coenzyme A biosynthesis |
Saccharomyces cerevisiae |
Purine fermentation |
Saccharomyces cerevisiae |
Methionine degradation |
Saccharomyces cerevisiae |
Proteasome degradation |
Caenorhabditis elegans |
Beta-oxidation of unsaturated fatty acids |
Caenorhabditis elegans |
Phosphatidic acid and phospholipid biosynthesis |
Saccharomyces cerevisiae |
Glycogen catabolism |
Saccharomyces cerevisiae |
TCA cycle |
Saccharomyces cerevisiae |
Fatty acid beta-oxidation 3 |
Caenorhabditis elegans |
Glutamate degradation III |
Saccharomyces cerevisiae |
MAPK signaling pathway |
Saccharomyces cerevisiae |
Glycolysis and gluconeogenesis |
Saccharomyces cerevisiae |
Eukaryotic transcription initiation |
Caenorhabditis elegans |
Phospholipid biosynthesis |
Saccharomyces cerevisiae |
Mitochondrial unfolded-protein response |
Caenorhabditis elegans |
Ergosterol biosynthesis |
Saccharomyces cerevisiae |
Tyrosine biosynthesis |
Saccharomyces cerevisiae |
Cytoplasmic ribosomal proteins |
Caenorhabditis elegans |
Lactose degradation and galactose metabolism |
Saccharomyces cerevisiae |
Arginine degradation |
Saccharomyces cerevisiae |
Octane oxidation |
Saccharomyces cerevisiae |
Glycerol teichoic acid biosynthesis |
Saccharomyces cerevisiae |
Phenylalanine degradation |
Saccharomyces cerevisiae |
Anaerobic respiration |
Saccharomyces cerevisiae |
Dauer formation |
Caenorhabditis elegans |
Toluene degradation |
Saccharomyces cerevisiae |
Mitochondrial tRNA synthetases |
Saccharomyces cerevisiae |
Pentose phosphate pathway 2 |
Saccharomyces cerevisiae |
Asparagine biosynthesis |
Saccharomyces cerevisiae |
Vulval development and SynMuv |
Caenorhabditis elegans |
Trehalose degradation, low osmolarity |
Saccharomyces cerevisiae |
Lipases biosynthesis |
Saccharomyces cerevisiae |
Mismatch repair |
Caenorhabditis elegans |
Homologous recombination |
Caenorhabditis elegans |
Glutamate biosynthesis |
Saccharomyces cerevisiae |
NAD biosynthesis |
Saccharomyces cerevisiae |
Fatty acid oxidation |
Saccharomyces cerevisiae |
De novo biosynthesis of pyrimidine ribonucleotides |
Saccharomyces cerevisiae |
Pyrimidine ribonucleotide salvage pathways |
Saccharomyces cerevisiae |
Glycolysis and Gluconeogenesis |
Caenorhabditis elegans |
Phospholipid biosynthesis |
Saccharomyces cerevisiae |
Electron transport chain |
Bos taurus |
Kit receptor signaling pathway |
Bos taurus |
Metapathway biotransformation |
Bos taurus |
Osteoclast signaling |
Bos taurus |
Amino acid conjugation of benzoic acid |
Bos taurus |
Wnt signaling pathway and pluripotency |
Bos taurus |
TCR signaling pathway |
Bos taurus |
Ketone bodies synthesis and degradation |
Bos taurus |
Wnt signaling pathway |
Bos taurus |
Apoptosis |
Bos taurus |
FAS pathway and stress induction of HSP regulation |
Bos taurus |
Hedgehog signaling pathway |
Bos taurus |
Notch signaling pathway |
Bos taurus |
IL-3 signaling pathway |
Bos taurus |
ACE inhibitor pathway |
Bos taurus |
Inflammatory response pathway |
Bos taurus |
TNF-alpha signaling pathway |
Bos taurus |
Oxidative stress response |
Bos taurus |
GPCRs, class C metabotropic glutamate, pheromone |
Bos taurus |
Actin cytoskeleton regulation |
Bos taurus |
Toll-like receptor signaling pathway |
Bos taurus |
Integrin-mediated cell adhesion |
Bos taurus |
Osteoblast signaling |
Bos taurus |
Proteasome degradation |
Bos taurus |
S1P receptor signal transduction |
Bos taurus |
Cell cycle |
Bos taurus |
Escherichia coli K-12 peripherome |
Escherichia coli |
NAD biosynthesis I from aspartate |
Escherichia coli |
NAD salvage pathway I |
Escherichia coli |
NAD salvage pathway II |
Escherichia coli |
NAD salvage pathway III |
Escherichia coli |
Acetaminophen synthesis |
Escherichia coli |
Cardiac progenitor differentiation |
Bos taurus |
SREBF and miR33 in cholesterol and lipid homeostasis |
Bos taurus |
miRNA biogenesis |
Bos taurus |
NOD pathway |
Bos taurus |
Vitamin D metabolism |
Bos taurus |
Neurotransmitter clearance in synaptic cleft |
Bos taurus |
Biogenic amine synthesis |
Bos taurus |
IL-17 signaling pathway |
Bos taurus |
Effects of nitric oxide |
Bos taurus |
Vitamin B12 metabolism |
Bos taurus |
Arrhythmogenic right ventricular cardiomyopathy |
Bos taurus |
PDGF pathway |
Bos taurus |
Membrane trafficking |
Bos taurus |
Ganglio sphingolipid metabolism |
Bos taurus |
Differentiation pathway |
Bos taurus |
Endoderm differentiation |
Bos taurus |
DDX1 as a regulatory component of the Drosha microprocessor |
Bos taurus |
Urea cycle and metabolism of amino groups |
Bos taurus |
Endothelin pathways |
Bos taurus |
Aflatoxin B1 metabolism |
Bos taurus |
Blood clotting cascade |
Bos taurus |
Nicotine activity on chromaffin cells |
Bos taurus |
Selenium micronutrient network |
Bos taurus |
Alanine and aspartate metabolism |
Bos taurus |
Corticotropin-releasing hormone |
Bos taurus |
Heart development |
Bos taurus |
Catalytic cycle of mammalian FMOs |
Bos taurus |
Septum site determination |
Escherichia coli |
Central carbon metabolism |
Escherichia coli |
SK UDPglcnac |
Escherichia coli |
Peptidoglycan cytoplasmic synthesis and recycling pathways |
Escherichia coli |
Salmonella virulence regulatory network |
Escherichia coli |
Heme biosynthesis |
Bos taurus |
Hypertrophy model |
Bos taurus |
Alpha 6 beta 4 signaling pathway |
Bos taurus |
Estrogen signaling pathway |
Bos taurus |
Methylation pathways |
Bos taurus |
Oxidative phosphorylation |
Bos taurus |
EPO receptor signaling |
Bos taurus |
Cytokines and inflammatory response |
Bos taurus |
Arachidonate epoxygenase / epoxide hydrolase |
Bos taurus |
Peptide GPCRs |
Bos taurus |
GPCRs, class B secretin-like |
Bos taurus |
IL-7 signaling pathway |
Bos taurus |
Triacylglyceride synthesis |
Bos taurus |
Androgen receptor signaling pathway |
Bos taurus |
Type II interferon signaling (IFNG) |
Bos taurus |
Fatty acid biosynthesis |
Bos taurus |
mRNA Processing |
Bos taurus |
Steroid biosynthesis |
Bos taurus |
B cell receptor signaling pathway |
Bos taurus |
Glycolysis and gluconeogenesis |
Bos taurus |
Pentose phosphate pathway |
Bos taurus |
Nod-like receptor (NLR) signaling pathway |
Bos taurus |
Statin pathway |
Bos taurus |
Calcium regulation in cardiac cell |
Bos taurus |
Hepatocyte growth factor receptor signaling |
Bos taurus |
TGF-beta receptor signaling |
Bos taurus |
ID signaling pathway |
Bos taurus |
Estrogen metabolism |
Bos taurus |
Complement and coagulation cascades |
Bos taurus |
Matrix metalloproteinases |
Bos taurus |
G13 signaling pathway |
Bos taurus |
Eukaryotic transcription initiation |
Bos taurus |
Nuclear receptors |
Bos taurus |
Cholesterol biosynthesis |
Bos taurus |
GPCRs, class A rhodopsin-like |
Bos taurus |
Glycogen metabolism |
Bos taurus |
Monoamine GPCRs |
Bos taurus |
Oxidation by cytochrome P450 |
Bos taurus |
Apoptosis modulation by HSP70 |
Bos taurus |
Growth hormone (GH) signaling |
Bos taurus |
Growth hormone receptor (GHR) signaling |
Bos taurus |
IGF-1 signaling |
Bos taurus |
Gonadotropin-releasing hormone (GnRH) signaling |
Bos taurus |
Iron metabolism in placenta |
Bos taurus |
Cori cycle |
Bos taurus |
Monoamine transport |
Bos taurus |
Folate-alcohol and cancer pathway |
Bos taurus |
Pilocytic astrocytoma |
Bos taurus |
AGE/RAGE pathway |
Bos taurus |
Apoptosis-related network due to altered Notch3 in ovarian cancer |
Bos taurus |
Constitutive androstane receptor pathway |
Bos taurus |
Regulation of toll-like receptor signaling pathway |
Bos taurus |
Mitochondrial gene expression |
Bos taurus |
Interactome of polycomb repressive complex 2 (PRC2) |
Bos taurus |
Serotonin transporter activity |
Bos taurus |
Gastric cancer network 2 |
Bos taurus |
BDNF signaling pathway |
Bos taurus |
Glycine metabolism |
Bos taurus |
Trans-sulfuration pathway |
Bos taurus |
Peroxisomal beta-oxidation of tetracosanoyl-CoA |
Bos taurus |
Apoptosis modulation and signaling |
Bos taurus |
Sulindac metabolic pathway |
Bos taurus |
Diclofenac metabolic pathway |
Bos taurus |
AMPK signaling |
Bos taurus |
Dopamine metabolism |
Bos taurus |
Osteopontin signaling |
Bos taurus |
Pathogenic Escherichia coli infection |
Bos taurus |
FSH signaling pathway |
Bos taurus |
IL1 and megakaryotyces in obesity |
Bos taurus |
Extracellular vesicle-mediated signaling in recipient cells |
Bos taurus |
RNA interference |
Bos taurus |
Quercetin and Nf-kB / AP-1 induced cell apoptosis |
Bos taurus |
Deregulation of Rab and Rab effector genes in bladder cancer |
Bos taurus |
Hematopoietic stem cell differentiation |
Bos taurus |
Microtubule cytoskeleton regulation |
Bos taurus |
Nicotine metabolism |
Bos taurus |
Spinal cord injury |
Bos taurus |
NRF2 pathway |
Bos taurus |
TSLP signaling pathway |
Bos taurus |
Neurotransmitter release cycle |
Bos taurus |
SREBP signaling |
Bos taurus |
Dopaminergic neurogenesis |
Bos taurus |
Focal adhesion |
Bos taurus |
Glycerophospholipid biosynthetic pathway |
Bos taurus |
Parkin-ubiquitin proteasomal system pathway |
Bos taurus |
Cell differentiation - index |
Bos taurus |
Hydrochloric acid secretion in parietal cells |
Bos taurus |
Retinoblastoma gene in cancer |
Bos taurus |
Glutathione metabolism |
Bos taurus |
Arylhydrocarbon receptor (AhR) signaling pathway |
Bos taurus |
Glucuronidation |
Bos taurus |
Interferon type I signaling pathways |
Bos taurus |
Influenza A virus infection |
Bos taurus |
Iron uptake and transport |
Bos taurus |
ATM signaling pathway |
Bos taurus |
Oxytocin signaling |
Bos taurus |
Aryl hydrocarbon receptor |
Bos taurus |
Thyroid stimulating hormone (TSH) signaling pathway |
Bos taurus |
NAD biosynthesis II from tryptophan |
Bos taurus |
Sphingolipid metabolism |
Bos taurus |
Primary focal segmental glomerulosclerosis (FSGS) |
Bos taurus |
Sulfation biotransformation reaction |
Bos taurus |
TWEAK signaling pathway |
Bos taurus |
Serotonin receptor 2 and ELK-SRF / GATA4 signaling |
Bos taurus |
Amyotrophic lateral sclerosis (ALS) |
Bos taurus |
Integrated cancer pathway |
Bos taurus |
Tryptophan metabolism |
Bos taurus |
Cardiac hypertrophic response |
Bos taurus |
Lidocaine metabolism |
Bos taurus |
Target of rapamycin (TOR) signaling |
Bos taurus |
Metastatic brain tumor |
Bos taurus |
Benzo(a)pyrene metabolism |
Bos taurus |
Tamoxifen metabolism |
Bos taurus |
RalA downstream regulated genes |
Bos taurus |
IL-1 signaling pathway |
Bos taurus |
Neural crest differentiation |
Bos taurus |
Leptin signaling pathway |
Bos taurus |
Fluoropyrimidine activity |
Bos taurus |
Oncostatin M signaling pathway |
Bos taurus |
Globo sphingolipid metabolism |
Bos taurus |
T cell receptor and co-stimulatory signaling |
Bos taurus |
Translation factors |
Bos taurus |
Insulin signaling |
Bos taurus |
IL-5 signaling pathway |
Bos taurus |
Striated muscle contraction |
Bos taurus |
Fatty acid omega-oxidation |
Bos taurus |
Small ligand GPCRs |
Bos taurus |
Eicosanoid synthesis |
Bos taurus |
IL-9 signaling pathway |
Bos taurus |
IL-6 signaling pathway |
Bos taurus |
Complement activation, classical pathway |
Bos taurus |
EGF/EGFR signaling pathway |
Bos taurus |
Nuclear receptors in lipid metabolism and toxicity |
Bos taurus |
DNA replication |
Bos taurus |
EBV LMP1 signaling |
Bos taurus |
Adipogenesis |
Bos taurus |
Transcriptional activation by NRF2 |
Bos taurus |
Mitochondrial long chain fatty acid beta-oxidation |
Bos taurus |
GPCRs, other |
Bos taurus |
Arylamine metabolism |
Bos taurus |
Prostaglandin synthesis and regulation |
Bos taurus |
MAPK signaling pathway |
Bos taurus |
TCA cycle |
Bos taurus |
Bone morphogenic protein signaling and regulation |
Homo sapiens |
Vitamin B12 metabolism |
Homo sapiens |
Selenium micronutrient network |
Homo sapiens |
Nicotine effect on dopaminergic neurons |
Homo sapiens |
One-carbon metabolism |
Homo sapiens |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
Homo sapiens |
Peptide GPCRs |
Homo sapiens |
T cell receptor and co-stimulatory signaling |
Homo sapiens |
Nanoparticle-mediated activation of receptor signaling |
Homo sapiens |
Nod-like receptor (NLR) signaling pathway |
Homo sapiens |
DDX1 as a regulatory component of the Drosha microprocessor |
Homo sapiens |
Interleukin-1 induced activation of NF-kB |
Homo sapiens |
Wnt/beta-catenin signaling pathway in leukemia |
Homo sapiens |
MAPK signaling pathway |
Homo sapiens |
Chemokine signaling pathway |
Homo sapiens |
Kennedy pathway from sphingolipids |
Homo sapiens |
Tumor suppressor activity of SMARCB1 |
Homo sapiens |
Wnt signaling |
Homo sapiens |
miRNA degrading enzymes |
Homo sapiens |
Control of immune tolerance by vasoactive intestinal peptide |
Homo sapiens |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
Homo sapiens |
Eicosanoid metabolism via cytochrome P450 monooxygenases pathway |
Homo sapiens |
Glycosaminoglycan degradation |
Homo sapiens |
GDNF/RET signaling axis |
Homo sapiens |
DNA repair pathways, full network |
Homo sapiens |
Iron-sulfur cluster biogenesis |
Homo sapiens |
Diet-dependent trimethylamine/trimethylamine N-oxide metabolism |
Homo sapiens |
Isoglobo series sphingolipids |
Homo sapiens |
Carnosine metabolism of glial cells |
Homo sapiens |
Male steroid hormones in cardiomyocyte energy metabolism |
Homo sapiens |
8p23.1 copy number variation syndrome |
Homo sapiens |
13q12 or CRYL1 copy number variation |
Homo sapiens |
8q11.23 (RB1CC1) copy number variation |
Homo sapiens |
Pentose phosphate metabolism |
Homo sapiens |
Ganglio sphingolipid metabolism |
Homo sapiens |
Glycine metabolism |
Homo sapiens |
RANKL/RANK signaling pathway |
Homo sapiens |
Gastric cancer network 2 |
Homo sapiens |
Small ligand GPCRs |
Homo sapiens |
Cocaine metabolism |
Homo sapiens |
Hair follicle development: organogenesis - part 2 of 3 |
Homo sapiens |
Endoderm differentiation |
Homo sapiens |
Biochemical pathways: part I |
Homo sapiens |
Mitochondrial long chain fatty acid beta-oxidation |
Homo sapiens |
Nanomaterial-induced inflammasome activation |
Homo sapiens |
PI3K/AKT/mTOR - vitamin D3 signaling |
Homo sapiens |
MET in type 1 papillary renal cell carcinoma |
Homo sapiens |
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma |
Homo sapiens |
Ophthalmate biosynthesis in hepatocytes |
Homo sapiens |
Transcription co-factors SKI and SKIL protein partners |
Homo sapiens |
Omega-9 fatty acid synthesis |
Homo sapiens |
Urea cycle and metabolism of amino groups |
Homo sapiens |
Familial hyperlipidemia type 4 |
Homo sapiens |
Roles of ceramides in development of insulin resistance |
Homo sapiens |
2q13 copy number variation syndrome |
Homo sapiens |
Estrogen metabolism |
Homo sapiens |
UDP-derived sugars synthesis in fibroblasts |
Homo sapiens |
ID signaling pathway |
Homo sapiens |
7q11.23 distal copy number variation |
Homo sapiens |
Glucose homeostasis |
Homo sapiens |
Vitamin A and carotenoid metabolism |
Homo sapiens |
Target of rapamycin signaling |
Homo sapiens |
Arrhythmogenic right ventricular cardiomyopathy |
Homo sapiens |
IL-9 signaling pathway |
Homo sapiens |
TNF-alpha signaling pathway |
Homo sapiens |
Quercetin and Nf-kB / AP-1 induced apoptosis |
Homo sapiens |
Nanomaterial induced apoptosis |
Homo sapiens |
Colchicine metabolic pathway |
Homo sapiens |
IL1 and megakaryocytes in obesity |
Homo sapiens |
IL-3 signaling pathway |
Homo sapiens |
Vitamin D receptor pathway |
Homo sapiens |
Nuclear receptors in lipid metabolism and toxicity |
Homo sapiens |
Caffeine and theobromine metabolism |
Homo sapiens |
IL6 signaling pathway |
Homo sapiens |
miR-222 in exercise-induced cardiac growth |
Homo sapiens |
DNA IR-damage and cellular response via ATR |
Homo sapiens |
Macrophage markers |
Homo sapiens |
ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
Homo sapiens |
Vitamins A and D - action mechanisms |
Homo sapiens |
MicroRNA network associated with chronic lymphocytic leukemia |
Homo sapiens |
Osteoblast differentiation and related diseases |
Homo sapiens |
Conversion of angiotensinogen to angiotensin II |
Homo sapiens |
Host-pathogen interaction of human coronaviruses - apoptosis |
Homo sapiens |
Fluoroacetic acid toxicity |
Homo sapiens |
ACE2 inhibition leads to pulmonary fibrosis |
Homo sapiens |
Lactate shuttle in glial cells |
Homo sapiens |
Primary ovarian insufficiency |
Homo sapiens |
Metabolic Epileptic Disorders |
Homo sapiens |
Polyol pathway |
Homo sapiens |
Serotonin receptor 2 and ELK-SRF/GATA4 signaling |
Homo sapiens |
Iron metabolism in placenta |
Homo sapiens |
Neural crest differentiation |
Homo sapiens |
Parkin-ubiquitin proteasomal system pathway |
Homo sapiens |
GPCRs, class B secretin-like |
Homo sapiens |
Wnt signaling pathway |
Homo sapiens |
EDA signaling in hair follicle development |
Homo sapiens |
Oxidative damage response |
Homo sapiens |
Wnt signaling pathway and pluripotency |
Homo sapiens |
mRNA processing |
Homo sapiens |
PTF1A related regulatory pathway |
Homo sapiens |
Ciliary landscape |
Homo sapiens |
Relationship between inflammation, COX-2 and EGFR |
Homo sapiens |
Disruption of postsynaptic signaling by CNV |
Homo sapiens |
GPCRs, class C metabotropic glutamate, pheromone |
Homo sapiens |
SARS-CoV-2 innate immunity evasion and cell-specific immune response |
Homo sapiens |
Retinol metabolism |
Homo sapiens |
Autophagy in pancreatic ductal adenocarcinoma |
Homo sapiens |
13q12.12 copy number variation |
Homo sapiens |
IDO metabolic pathway |
Homo sapiens |
Glucuronidation |
Homo sapiens |
DNA damage response (only ATM dependent) |
Homo sapiens |
Glutathione metabolism |
Homo sapiens |
IL-6 signaling pathway |
Rattus norvegicus |
PCSK9-mediated LDL receptor degradation |
Homo sapiens |
Hypothetical craniofacial development pathway |
Homo sapiens |
Canonical and non-canonical Notch signaling |
Homo sapiens |
Canonical and non-canonical TGF-B signaling |
Homo sapiens |
ATR signaling |
Homo sapiens |
Wnt signaling pathway |
Mus musculus |
Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine |
Homo sapiens |
GPCRs, other |
Mus musculus |
Neurotransmitter disorders |
Homo sapiens |
Methionine metabolism leading to sulfur amino acids and related disorders |
Homo sapiens |
Effect of progerin on genes involved in progeria |
Homo sapiens |
Alternative pathway of fetal androgen synthesis |
Homo sapiens |
Sphingolipid metabolism overview |
Homo sapiens |
Iron metabolism disorders |
Homo sapiens |
Disorders of bile acid synthesis and biliary transport |
Homo sapiens |
Acetylcholine synthesis |
Homo sapiens |
Growth factors and hormones in beta cell proliferation |
Homo sapiens |
p53 pathway |
Rattus norvegicus |
Sulfur amino acid biosynthesis |
Saccharomyces cerevisiae |
Heme biosynthesis |
Saccharomyces cerevisiae |
Hedgehog-related genes |
Caenorhabditis elegans |
Fructose and mannose metabolism |
Mycobacterium tuberculosis |
Synaptic vesicle pathway |
Homo sapiens |
Irinotecan pathway |
Homo sapiens |
Apoptosis |
Homo sapiens |
Hematopoietic stem cell differentiation |
Homo sapiens |
Hypoxia-mediated EMT and stemness |
Homo sapiens |
Photodynamic therapy-induced NF-kB survival signaling |
Homo sapiens |
BDNF-TrkB signaling |
Homo sapiens |
Cell-type dependent selectivity of CCK2R signaling |
Homo sapiens |
T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection |
Homo sapiens |
Metabolism of sphingolipids in ER and Golgi apparatus |
Homo sapiens |
Immune response to tuberculosis |
Homo sapiens |
Chromosomal and microsatellite instability in colorectal cancer |
Homo sapiens |
Metabolic pathway of LDL, HDL and TG, including diseases |
Homo sapiens |
Lipids measured in liver metastasis from breast cancer |
Mus musculus |
Spina bifida |
Homo sapiens |
Ulcerative colitis signaling |
Homo sapiens |
Disorders of fructose metabolism |
Homo sapiens |
mRNA vaccine activation of dendritic cell and induction of IFN-1 |
Homo sapiens |
Inflammatory bowel disease signaling |
Homo sapiens |
Estradiol regulation in porto-sinusoidal vascular disease |
Homo sapiens |
Ether lipid biosynthesis |
Homo sapiens |
Fatty acids and lipoproteins transport in hepatocytes |
Homo sapiens |
Involvement of δ-secretase in neurodegenerative diseases |
Homo sapiens |
Complement activation |
Homo sapiens |
Physiological and pathological hypertrophy of the heart |
Homo sapiens |
Amino acid conjugation of benzoic acid |
Sus scrofa |
Mammary gland development pathway - Embryonic development (Stage 1 of 4) |
Homo sapiens |
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) |
Homo sapiens |
ERK pathway in Huntington's disease |
Homo sapiens |
Serotonin and anxiety-related events |
Homo sapiens |
Ethanol metabolism production of ROS by CYP2E1 |
Homo sapiens |
Hippo-Merlin signaling dysregulation |
Homo sapiens |
Aspirin and miRNAs |
Homo sapiens |
Hypoxia-dependent self-renewal of myoblasts |
Mus musculus |
Amino acid transport defects (IEMs) |
Homo sapiens |
Regulation of actin cytoskeleton |
Homo sapiens |
Nephrotoxcicity adverse outcome pathway |
Homo sapiens |
Role of ROS in COVID-19 endothelial dysfunction |
Homo sapiens |
Rubinstein-Taybi syndrome 1 |
Homo sapiens |
Sudden infant death syndrome (SIDS) susceptibility pathways |
Homo sapiens |
Tryptophan metabolism |
Mus musculus |
Phase I biotransformations, non-P450 |
Homo sapiens |
Androgen receptor network in prostate cancer |
Homo sapiens |
High-osmolarity glycerol (HOG) pathway |
Saccharomyces cerevisiae |
Evolocumab mechanism to reduce LDL cholesterol |
Homo sapiens |
Hepatitis C and hepatocellular carcinoma |
Homo sapiens |
Wnt signaling in kidney disease |
Mus musculus |
Prion disease pathway |
Homo sapiens |
Host-pathogen interaction of human coronaviruses - interferon induction |
Homo sapiens |
Mitochondrial fatty acid oxidation disorders |
Homo sapiens |
Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids |
Homo sapiens |
Pathways in cancer |
Homo sapiens |
Toll-like receptor signaling pathway |
Homo sapiens |
Nucleotide GPCRs |
Homo sapiens |
Gastric acid production |
Homo sapiens |
Oxidative stress response |
Homo sapiens |
Type 2 papillary renal cell carcinoma |
Homo sapiens |
Ethanol metabolism resulting in production of ROS by CYP2E1 |
Rattus norvegicus |
Urea cycle and associated pathways |
Homo sapiens |
22q11.2 copy number variation syndrome |
Homo sapiens |
Hemesynthesis defects and porphyrias |
Homo sapiens |
Omega-6-fatty acids in senescence |
Homo sapiens |
EPAC1 and PKA reduction of retinal inflammation |
Homo sapiens |
SREBF and miR33 in cholesterol and lipid homeostasis |
Homo sapiens |
Liver steatosis adverse outcome pathway |
Homo sapiens |
Hedgehog signaling pathway |
Homo sapiens |
Ciliopathies |
Homo sapiens |
Activation of NLRP3 inflammasome by SARS-CoV-2 |
Homo sapiens |
Markers of kidney cell lineage |
Homo sapiens |
Glioblastoma signaling pathways |
Homo sapiens |
Histone modifications |
Homo sapiens |
Gene regulatory network modeling somitogenesis |
Homo sapiens |
Hypothesized pathways in pathogenesis of cardiovascular disease |
Homo sapiens |
miRNA regulation of p53 pathway in prostate cancer |
Homo sapiens |
GABA receptor signaling |
Homo sapiens |
Epithelial to mesenchymal transition in colorectal cancer |
Homo sapiens |
Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases |
Homo sapiens |
Measles virus infection |
Homo sapiens |
PKC-gamma calcium signaling pathway in ataxia |
Homo sapiens |
Disorders in ketolysis |
Homo sapiens |
Amino acid metabolism in triple-negative breast cancer cells |
Homo sapiens |
Extrafollicular and follicular B cell activation by SARS-CoV-2 |
Homo sapiens |
Bacterial ceramide synthesis |
Caulobacter vibrioides |
10q22q23 copy number variation |
Homo sapiens |
Hunger and satiety |
Homo sapiens |
Interferon type I signaling pathways |
Homo sapiens |
Acetylcholine synthesis |
Bos taurus |
Mismatch repair |
Bos taurus |
Homologous recombination |
Bos taurus |
Nucleotide GPCRs |
Bos taurus |
TGF-beta signaling pathway |
Bos taurus |
G protein signaling pathways |
Bos taurus |
IL-4 signaling pathway |
Bos taurus |
Endochondral ossification |
Bos taurus |
Cytoplasmic ribosomal proteins |
Bos taurus |
Folate metabolism |
Bos taurus |
G1 to S cell cycle control |
Bos taurus |
Heme biosynthesis |
Canis familiaris |
Eicosanoid synthesis |
Canis familiaris |
IL-2 signaling pathway |
Canis familiaris |
EGFR1 signaling pathway |
Canis familiaris |
Nuclear receptors in lipid metabolism and toxicity |
Canis familiaris |
Adipogenesis |
Canis familiaris |
EPO receptor signaling |
Canis familiaris |
Cytokines and inflammatory response |
Canis familiaris |
MAPK signaling pathway |
Canis familiaris |
Biogenic amine synthesis |
Canis familiaris |
Electron transport chain |
Canis familiaris |
Kit receptor signaling pathway |
Canis familiaris |
Blood clotting cascade |
Canis familiaris |
Tryptophan metabolism |
Canis familiaris |
Wnt signaling pathway and pluripotency |
Canis familiaris |
Androgen receptor signaling pathway |
Canis familiaris |
Ketone bodies synthesis and degradation |
Canis familiaris |
Wnt signaling pathway |
Canis familiaris |
FAS pathway and stress induction of HSP regulation |
Canis familiaris |
Hedgehog signaling pathway |
Canis familiaris |
mRNA Processing |
Canis familiaris |
Notch signaling pathway |
Canis familiaris |
ACE inhibitor pathway |
Canis familiaris |
Mismatch repair |
Canis familiaris |
Homologous recombination |
Canis familiaris |
p38 MAPK signaling pathway |
Canis familiaris |
Statin pathway |
Canis familiaris |
Calcium regulation in cardiac cells |
Canis familiaris |
G protein signaling pathways |
Canis familiaris |
ID signaling pathway |
Canis familiaris |
Polyol pathway |
Canis familiaris |
Matrix metalloproteinases |
Canis familiaris |
G13 signaling pathway |
Canis familiaris |
Delta-Notch signaling pathway |
Canis familiaris |
Eukaryotic transcription initiation |
Canis familiaris |
Nuclear receptors |
Canis familiaris |
Integrin-mediated cell adhesion |
Canis familiaris |
Cholesterol biosynthesis |
Canis familiaris |
Glycogen metabolism |
Canis familiaris |
Monoamine GPCRs |
Canis familiaris |
G1 to S cell cycle control |
Canis familiaris |
Cell cycle |
Canis familiaris |
Glycolysis and gluconeogenesis |
Mycobacterium tuberculosis |
Histidine metabolism |
Mycobacterium tuberculosis |
Ascorbate and aldarate metabolism |
Mycobacterium tuberculosis |
D-arginine and D-ornithine metabolism |
Mycobacterium tuberculosis |
Lipoic acid metabolism |
Mycobacterium tuberculosis |
TCA cycle |
Mycobacterium tuberculosis |
Transcription initiation by sigma factors |
Mycobacterium tuberculosis |
Glyoxylate cycle |
Mycobacterium tuberculosis |
Glyoxylate, anapleurotic and succinyl CoA (GAS) pathway |
Mycobacterium tuberculosis |
Vascular smooth muscle contraction |
Bos taurus |
Serotonin receptor 2 and STAT3 signaling |
Bos taurus |
Type II diabetes mellitus |
Bos taurus |
Histone modifications |
Bos taurus |
TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) |
Bos taurus |
Semaphorin interactions |
Bos taurus |
Interleukin-11 signaling pathway |
Bos taurus |
Estrogen receptor pathway |
Bos taurus |
Gastric cancer network 1 |
Bos taurus |
Type III interferon signaling |
Bos taurus |
Interleukin-1 (IL-1) structural pathway |
Bos taurus |
Nicotine activity on dopaminergic neurons |
Bos taurus |
Mesodermal commitment pathway |
Bos taurus |
Colchicine metabolic pathway |
Bos taurus |
Felbamate metabolism |
Bos taurus |
Glial cell differentiation |
Bos taurus |
Aryl hydrocarbon receptor pathway |
Bos taurus |
Ectoderm differentiation |
Bos taurus |
Nucleotide metabolism |
Bos taurus |
Gene regulatory network modelling somitogenesis |
Bos taurus |
Synaptic vesicle pathway |
Bos taurus |
Exercise-induced circadian regulation |
Bos taurus |
Thyroxine (thyroid hormone) production |
Bos taurus |
Butyrate-induced histone acetylation |
Bos taurus |
TCA cycle nutrient use and invasiveness of ovarian cancer |
Bos taurus |
Codeine and morphine metabolism |
Bos taurus |
Serotonin receptor 4/6/7 and NR3C signaling |
Bos taurus |
Myometrial relaxation and contraction pathways |
Bos taurus |
Biosynthesis of the three types of mycolic acids |
Mycobacterium tuberculosis |
Heme biosynthesis |
Pan troglodytes |
Fatty acid omega-oxidation |
Pan troglodytes |
Eicosanoid synthesis |
Pan troglodytes |
EGFR1 signaling pathway |
Pan troglodytes |
Nuclear receptors in lipid metabolism and toxicity |
Pan troglodytes |
EPO receptor signaling |
Pan troglodytes |
Cytokines and inflammatory response |
Pan troglodytes |
MAPK signaling pathway |
Pan troglodytes |
Kit receptor signaling pathway |
Pan troglodytes |
Blood clotting cascade |
Pan troglodytes |
Osteoclast signaling |
Pan troglodytes |
Ketone bodies synthesis and degradation |
Pan troglodytes |
FAS pathway and stress induction of HSP regulation |
Pan troglodytes |
Hedgehog signaling pathway |
Pan troglodytes |
mRNA Processing |
Pan troglodytes |
Notch signaling pathway |
Pan troglodytes |
Nod-like receptor (NLR) signaling pathway |
Pan troglodytes |
ACE inhibitor pathway |
Pan troglodytes |
p38 MAPK signaling pathway |
Pan troglodytes |
Statin pathway |
Pan troglodytes |
Calcium regulation in cardiac cells |
Pan troglodytes |
Aflatoxin B1 metabolism |
Pan troglodytes |
Hepatocyte growth factor receptor signaling |
Pan troglodytes |
G protein signaling pathways |
Pan troglodytes |
ID signaling pathway |
Pan troglodytes |
Polyol pathway |
Pan troglodytes |
Matrix metalloproteinases |
Pan troglodytes |
Nuclear receptors |
Pan troglodytes |
Integrin-mediated cell adhesion |
Pan troglodytes |
Cholesterol biosynthesis |
Pan troglodytes |
Glycogen metabolism |
Pan troglodytes |
Osteoblast signaling |
Pan troglodytes |
Monoamine GPCRs |
Pan troglodytes |
G1 to S cell cycle control |
Pan troglodytes |
Apoptosis modulation by HSP70 |
Pan troglodytes |
Cell cycle |
Pan troglodytes |
IL-2 signaling pathway |
Bos taurus |
Non-homologous end joining |
Bos taurus |
Primary carbon metabolism |
Populus trichocarpa |
Calvin cycle |
Populus trichocarpa |
Chloroplast electron transport chain |
Populus trichocarpa |
Glycolysis |
Populus trichocarpa |
Krebs cycle |
Populus trichocarpa |
Isoprenoid precursor biosynthesis in Pf apicoplasts |
Plasmodium falciparum |
Adipogenesis |
Pan troglodytes |
Androgen receptor signaling pathway |
Pan troglodytes |
Wnt signaling pathway |
Pan troglodytes |
Homologous recombination |
Pan troglodytes |
G13 signaling pathway |
Pan troglodytes |
Delta-Notch signaling pathway |
Pan troglodytes |
Eukaryotic transcription initiation |
Pan troglodytes |
Heme biosynthesis |
Anopheles gambiae |
EBV LMP1 signaling |
Anopheles gambiae |
TCA cycle |
Anopheles gambiae |
mRNA processing |
Anopheles gambiae |
Pentose phosphate pathway |
Anopheles gambiae |
Notch signaling pathway |
Anopheles gambiae |
Mismatch repair |
Anopheles gambiae |
Polyol pathway |
Anopheles gambiae |
Eukaryotic transcription initiation |
Anopheles gambiae |
Cytoplasmic ribosomal proteins |
Anopheles gambiae |
Chicken limb development |
Gallus gallus |
Toll, IMD, JAK/STAT pathways for immune response to pathogens |
Anopheles gambiae |
EGFR1 signaling pathway |
Gallus gallus |
Nuclear receptors in lipid metabolism and toxicity |
Gallus gallus |
Mitochondrial long chain fatty acid beta-oxidation |
Gallus gallus |
EPO receptor signaling |
Gallus gallus |
MAPK signaling pathway |
Gallus gallus |
Kit receptor signaling pathway |
Gallus gallus |
Blood clotting cascade |
Gallus gallus |
Wnt signaling pathway and pluripotency |
Gallus gallus |
Triacylglyceride synthesis |
Gallus gallus |
Ketone bodies synthesis and degradation |
Gallus gallus |
Wnt signaling pathway |
Gallus gallus |
Apoptosis |
Gallus gallus |
FAS pathway and stress induction of HSP regulation |
Gallus gallus |
Hedgehog signaling pathway |
Gallus gallus |
mRNA processing |
Gallus gallus |
Notch signaling pathway |
Gallus gallus |
Nod-like receptor (NLR) signaling pathway |
Gallus gallus |
ACE inhibitor pathway |
Gallus gallus |
Mismatch repair |
Gallus gallus |
p38 MAPK signaling pathway |
Gallus gallus |
Homologous recombination |
Gallus gallus |
Retinol metabolism |
Gallus gallus |
Calcium regulation in cardiac cells |
Gallus gallus |
G protein signaling pathways |
Gallus gallus |
Inhibitor of DNA binding (ID) signaling pathway |
Gallus gallus |
Matrix metalloproteinases |
Gallus gallus |
Regulation of actin cytoskeleton |
Gallus gallus |
G13 signaling pathway |
Gallus gallus |
Delta-Notch signaling pathway |
Gallus gallus |
Eukaryotic transcription initiation |
Gallus gallus |
Nuclear receptors |
Gallus gallus |
Integrin-mediated cell adhesion |
Gallus gallus |
Cholesterol biosynthesis |
Gallus gallus |
Glycogen metabolism |
Gallus gallus |
Monoamine GPCRs |
Gallus gallus |
G1 to S cell cycle control |
Gallus gallus |
Cell cycle |
Gallus gallus |
SRF and miRs in smooth muscle differentiation and proliferation |
Homo sapiens |
Type III interferon signaling |
Homo sapiens |
Butyrate-induced histone acetylation |
Homo sapiens |
Dopaminergic neurogenesis |
Homo sapiens |
Microglia pathogen phagocytosis pathway |
Homo sapiens |
Metabolic reprogramming in colon cancer |
Homo sapiens |
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
Homo sapiens |
Tryptophan metabolism |
Homo sapiens |
1q21.1 copy number variation syndrome |
Homo sapiens |
Clock-controlled autophagy in bone metabolism |
Homo sapiens |
Hippocampal synaptogenesis and neurogenesis |
Homo sapiens |
Sebaleic acid formation and metabolism |
Homo sapiens |
Osteoclast signaling |
Homo sapiens |
miRNA regulation of DNA damage response |
Homo sapiens |
Transcription factors regulate miRNAs related to cardiac hypertrophy |
Homo sapiens |
Eicosanoid synthesis |
Homo sapiens |
Cori cycle |
Homo sapiens |
Cell differentiation - expanded index |
Homo sapiens |
IL-7 signaling pathway |
Homo sapiens |
Fatty acid omega-oxidation |
Homo sapiens |
Adipogenesis |
Homo sapiens |
S1P receptor signal transduction |
Homo sapiens |
NOTCH1 regulation of endothelial cell calcification |
Homo sapiens |
Transcription factor regulation in adipogenesis |
Homo sapiens |
TLR4 signaling and tolerance |
Homo sapiens |
NO/cGMP/PKG mediated neuroprotection |
Homo sapiens |
SCFA and skeletal muscle substrate metabolism |
Homo sapiens |
Statin inhibition of cholesterol production |
Homo sapiens |
Translation inhibitors in chronically activated PDGFRA cells |
Homo sapiens |
Cancer immunotherapy by PD-1 blockade |
Homo sapiens |
Kynurenine pathway and links to cell senescence |
Homo sapiens |
Vasopressin-regulated water reabsorption |
Homo sapiens |
Prostaglandin and leukotriene metabolism in senescence |
Homo sapiens |
Warburg effect modulated by deubiquitinating enzymes and their substrates |
Homo sapiens |
Bardet-Biedl syndrome |
Homo sapiens |
Farnesyl to CoQ10 metabolism |
Homo sapiens |
Glucocorticoid biosynthesis |
Homo sapiens |
17q12 copy number variation syndrome |
Homo sapiens |
Induction of autophagy and toll-like receptor signaling pathways by graphene oxide |
Homo sapiens |
4p16.3 copy number variation |
Homo sapiens |
17p13.3 (YWHAE) copy number variation |
Homo sapiens |
Metapathway biotransformation Phase I and II |
Homo sapiens |
Integrin-mediated cell adhesion |
Homo sapiens |
Nanoparticle triggered regulated necrosis |
Homo sapiens |
exRNA mechanism of action and biogenesis |
Homo sapiens |
Felbamate metabolism |
Homo sapiens |
Extracellular vesicle-mediated signaling in recipient cells |
Homo sapiens |
Pre-implantation embryo |
Homo sapiens |
Methionine de novo and salvage pathway |
Homo sapiens |
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling |
Homo sapiens |
NAD+ metabolism |
Homo sapiens |
NAD+ biosynthetic pathways |
Homo sapiens |
BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation |
Homo sapiens |
Non-small cell lung cancer |
Homo sapiens |
Fragile X syndrome |
Homo sapiens |
Overview of interferons-mediated signaling pathway |
Homo sapiens |
Biomarkers for pyrimidine metabolism disorders |
Homo sapiens |
MAP3K1 role in promoting and blocking gonadal determination |
Homo sapiens |
Unfolded protein response |
Homo sapiens |
Development of ureteric collection system |
Homo sapiens |
Pathophysiological roles of DUX4 in FSHD1 |
Homo sapiens |
Smith-Magenis and Potocki-Lupski syndrome copy number variation |
Homo sapiens |
Electron transport chain: OXPHOS system in mitochondria |
Homo sapiens |
Folate-alcohol and cancer pathway hypotheses |
Homo sapiens |
Nuclear receptors |
Homo sapiens |
Dopamine metabolism |
Homo sapiens |
PDGF pathway |
Homo sapiens |
Complement system |
Homo sapiens |
let-7 inhibition of ES cell reprogramming |
Homo sapiens |
Photodynamic therapy-induced HIF-1 survival signaling |
Homo sapiens |
Metabolism of tetrahydrocannabinol (THC) |
Homo sapiens |
Caloric restriction and aging |
Homo sapiens |
Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer |
Homo sapiens |
16p11.2 proximal deletion syndrome |
Homo sapiens |
Congenital generalized lipodystrophy |
Homo sapiens |
Metabolic pathways of fibroblasts |
Homo sapiens |
Selenium metabolism / selenoproteins |
Mus musculus |
TGF-beta signaling pathway |
Mus musculus |
Estrogen signaling |
Mus musculus |
Oxidative phosphorylation |
Mus musculus |
Arachidonate epoxygenase / epoxide hydrolase |
Mus musculus |
Metapathway biotransformation |
Mus musculus |
Type II interferon signaling (IFNG) |
Mus musculus |
Apoptosis |
Mus musculus |
Mismatch repair |
Mus musculus |
Homologous recombination |
Mus musculus |
Retinol metabolism |
Mus musculus |
Mitochondrial gene expression |
Mus musculus |
Polyol pathway |
Mus musculus |
SIDS susceptibility pathways |
Mus musculus |
Selenium micronutrient network |
Mus musculus |
Folic acid network |
Mus musculus |
Oxidation by cytochrome P450 |
Mus musculus |
Hypertrophy model |
Danio rerio |
MAPK signaling pathway |
Danio rerio |
Apoptosis |
Danio rerio |
Glycogen metabolism |
Danio rerio |
GPCRs, odorant |
Mus musculus |
GPCRs, orphan |
Mus musculus |
Oxidative damage response |
Mus musculus |
Dopaminergic neurogenesis |
Mus musculus |
IL-5 signaling pathway |
Mus musculus |
Glycolysis and gluconeogenesis |
Mus musculus |
Iron homeostasis |
Mus musculus |
Cytoplasmic ribosomal proteins |
Mus musculus |
Glutathione metabolism |
Mus musculus |
Apoptosis modulation by HSP70 |
Mus musculus |
One-carbon metabolism and related pathways |
Mus musculus |
Kennedy pathway |
Mus musculus |
GPCRs, class A rhodopsin-like |
Mus musculus |
Heme biosynthesis |
Mus musculus |
Statin pathway |
Mus musculus |
Complement activation, classical pathway |
Mus musculus |
Ptf1a related regulatory pathway |
Mus musculus |
Hypertrophy model |
Mus musculus |
Heart development |
Mus musculus |
Serotonin receptor 2 and STAT3 signaling |
Mus musculus |
Serotonin and anxiety-related events |
Mus musculus |
Serotonin and anxiety |
Mus musculus |
BDNF pathway |
Mus musculus |
Cytokines and inflammatory response |
Mus musculus |
Macrophage markers |
Mus musculus |
PPAR signaling pathway |
Mus musculus |
Fatty acid oxidation |
Mus musculus |
G protein signaling pathways |
Mus musculus |
GPCRs, peptide |
Mus musculus |
miRNAs and TFs in iPS Cell Generation |
Mus musculus |
Alanine and aspartate metabolism |
Mus musculus |
Ovarian infertility |
Mus musculus |
Gene regulatory network modelling somitogenesis |
Mus musculus |
White fat cell differentiation |
Mus musculus |
miR302-367 promoting cardiomyocyte proliferation |
Mus musculus |
miR-222 in exercise-induced cardiac growth |
Mus musculus |
G13 signaling pathway |
Mus musculus |
Notch signaling pathway |
Mus musculus |
Histone modifications |
Mus musculus |
Eicosanoid synthesis |
Mus musculus |
Cytoplasmic ribosomal proteins |
Danio rerio |
Fatty acid biosynthesis |
Mus musculus |
ESC pluripotency pathways |
Mus musculus |
Fatty acid omega-oxidation |
Mus musculus |
p38 Mapk signaling pathway |
Mus musculus |
ApoE and miR-146 in inflammation and atherosclerosis |
Mus musculus |
Microglia pathogen phagocytosis pathway |
Mus musculus |
Parkinson's disease |
Mus musculus |
Hfe effect on hepcidin production |
Mus musculus |
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling |
Mus musculus |
IL-1 signaling pathway |
Mus musculus |
Robo4 and VEGF signaling pathways crosstalk |
Mus musculus |
IL-6 signaling pathway |
Mus musculus |
ACE inhibitor pathway |
Mus musculus |
miR-127 in mesendoderm differentiation |
Mus musculus |
Mitochondrial long chain fatty acid beta-oxidation |
Mus musculus |
Model of Fgf and Wnt crosstalk in tailbud |
Danio rerio |
Kit receptor signaling pathway |
Mus musculus |
G1 to S cell cycle control |
Mus musculus |
Glycerolipids and glycerophospholipids |
Mus musculus |
Omega-9 fatty acid synthesis |
Mus musculus |
PDGFR-alpha and STMN1 cooperate to exacerbate cytotoxic effects of vinblastine |
Mus musculus |
Matrix metalloproteinases |
Mus musculus |
Adipogenesis genes |
Mus musculus |
Elongation of (very) long chain fatty acids |
Mus musculus |
IL-2 signaling pathway |
Mus musculus |
DNA replication |
Danio rerio |
Osteoclast signaling |
Mus musculus |
GPCRs, class B secretin-like |
Mus musculus |
ACE inhibitor pathway |
Danio rerio |
Sphingolipid metabolism (integrated pathway) |
Mus musculus |
Regulation of Pgc1a expression by a Gsk3b-Tfeb signaling axis in skeletal muscle |
Mus musculus |
GDNF/RET signaling axis |
Mus musculus |
Alpha 6 beta 4 integrin signaling pathway |
Mus musculus |
Mapk signaling pathway |
Mus musculus |
Mitochondrial long chain fatty acid beta-oxidation |
Danio rerio |
Hypoxia-dependent proliferation of myoblasts |
Mus musculus |
Burn wound healing |
Mus musculus |
Nuclear Receptors |
Mus musculus |
Fibrin complement receptor 3 signaling pathway |
Mus musculus |
ID signaling pathway |
Mus musculus |
Lac-Phe pathway |
Mus musculus |
Dravet syndrome: Scn1a-A1783V point mutation model |
Mus musculus |
Leptin-insulin signaling overlap |
Mus musculus |
miR-1 in cardiac development |
Mus musculus |
Pentose phosphate pathway |
Mus musculus |
Amino acid metabolism |
Mus musculus |
Leptin and adiponectin |
Mus musculus |
Integrin-mediated cell adhesion |
Mus musculus |
Glutathione and one-carbon metabolism |
Mus musculus |
Arylamine metabolism |
Equus caballus |
Metapathway biotransformation |
Equus caballus |
Aflatoxin B1 metabolism |
Equus caballus |
Polyol pathway |
Equus caballus |
Insulin signaling |
Danio rerio |
Eicosanoid synthesis |
Danio rerio |
Nuclear receptors in lipid metabolism and toxicity |
Danio rerio |
Estrogen signaling |
Danio rerio |
Adipogenesis |
Danio rerio |
Oxidative phosphorylation |
Danio rerio |
EPO receptor signaling |
Danio rerio |
Peptide GPCRs |
Danio rerio |
Electron transport chain |
Danio rerio |
One-carbon metabolism |
Danio rerio |
Glycolysis and gluconeogenesis |
Danio rerio |
Selenium metabolism selenoproteins |
Danio rerio |
Oxidative stress response |
Danio rerio |
Polyol pathway |
Danio rerio |
IL-4 signaling pathway |
Danio rerio |
Toll-like receptor signaling pathway |
Danio rerio |
Integrin-mediated cell adhesion |
Danio rerio |
Cholesterol biosynthesis |
Danio rerio |
Monoamine GPCRs |
Danio rerio |
Cell cycle |
Danio rerio |
FGF signaling pathway |
Danio rerio |
Biogenic amine synthesis |
Danio rerio |
TCA cycle |
Danio rerio |
BMP signaling pathway |
Danio rerio |
Non-canonical Wnt pathway |
Danio rerio |
Seed development |
Oryza sativa |
Beta-alanine biosynthesis |
Oryza sativa |
Cardiolipin biosynthesis |
Oryza sativa |
Momilactone biosynthesis |
Oryza sativa |
Oryzalexin S biosynthesis |
Oryza sativa |
Geranylgeranyldiphosphate biosynthesis II (plastidic) |
Oryza sativa |
Methylerythritol phosphate pathway |
Oryza sativa |
DON mycotoxin biosynthesis |
Gibberella zeae |
Polar auxin transport |
Oryza sativa |
TCA cycle (plant) |
Oryza sativa |
Nodal signaling pathway |
Danio rerio |
Effect of L-carnitine on metabolism |
Danio rerio |
PPAR signaling pathway |
Danio rerio |
ERK1-ERK2 MAPK cascade |
Danio rerio |
CRD motif and sFRPs influence on Wnt signaling |
Danio rerio |
Biotic stress response gene network |
Oryza sativa |
G1 to S cell cycle control |
Danio rerio |
mRNA processing |
Danio rerio |
Acetylcholine synthesis |
Danio rerio |
Neural crest development |
Danio rerio |
Exercise-induced circadian regulation |
Danio rerio |
Ureide biosynthesis |
Oryza sativa |
Biotin metabolism |
Mycobacterium tuberculosis |
Flowering time pathway |
Hordeum vulgare |
Lipid metabolism pathway |
Homo sapiens |
Thiamine metabolic pathways |
Homo sapiens |
Cancer immunotherapy by CTLA4 blockade |
Homo sapiens |
FGF23 signaling in hypophosphatemic rickets and related disorders |
Homo sapiens |
Influence of laminopathies on Wnt signaling |
Homo sapiens |
Overlap between signal transduction pathways contributing to LMNA laminopathies |
Homo sapiens |
STING pathway in Kawasaki-like disease and COVID-19 |
Homo sapiens |
RAS and bradykinin pathways in COVID-19 |
Homo sapiens |
Acquired partial lipodystrophy / Barraquer-Simons syndrome |
Homo sapiens |
Copper metabolism |
Homo sapiens |
Biogenic amine synthesis |
Mus musculus |
Macrophage-stimulating protein (MSP) signaling network map |
Homo sapiens |
KCNQ2-related epilepsies |
Homo sapiens |
Monoamine GPCRs |
Homo sapiens |
Insulin signaling |
Mus musculus |
Angiogenesis |
Bos taurus |
MicroRNA for targeting cancer growth and vascularization in glioblastoma |
Homo sapiens |
NAD metabolism, sirtuins and aging |
Homo sapiens |
PI3K-Akt signaling pathway |
Homo sapiens |
Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors |
Homo sapiens |
Endochondral ossification with skeletal dysplasias |
Homo sapiens |
Glycolysis and gluconeogenesis |
Homo sapiens |
Steroid biosynthesis |
Mus musculus |
Notch signaling pathway |
Homo sapiens |
Wnt Signaling Pathway and Pluripotency |
Danio rerio |
AMP-activated protein kinase signaling |
Homo sapiens |
Drug induction of bile acid pathway |
Homo sapiens |
Mecp2 and associated Rett syndrome |
Mus musculus |
TGF-beta signaling pathway |
Homo sapiens |
MYD88 distinct input-output pathway |
Homo sapiens |
Krebs cycle disorders |
Homo sapiens |
Cerebral organic acidurias, including diseases |
Homo sapiens |
Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism |
Homo sapiens |
Monoterpene biosynthesis pathway in mint |
Vitis vinifera |
Burn wound healing |
Sus scrofa |
De novo NAD biosynthesis |
Saccharomyces cerevisiae |
GNAQ pathways in port-wine stain |
Homo sapiens |
Metapathway UDP-glucuronosyltransferases |
Caenorhabditis elegans |
Cholesterol biosynthesis pathway |
Homo sapiens |
Secretion of hydrochloric acid in parietal cells |
Homo sapiens |
One-carbon metabolism and related pathways |
Homo sapiens |
Degradation pathway of sphingolipids, including diseases |
Homo sapiens |
Hippo signaling regulation pathways |
Homo sapiens |
Endochondral ossification |
Homo sapiens |
Downregulation of ACE2 by SARS-CoV-2 spike protein |
Homo sapiens |
TGF-beta receptor signaling in skeletal dysplasias |
Homo sapiens |
Alzheimer's disease |
Homo sapiens |
Disorders of galactose metabolism |
Homo sapiens |
Disorders in ketone body synthesis |
Homo sapiens |
Chronic hyperglycemia impairment of neuron function |
Homo sapiens |
NF1 copy number variation syndrome |
Homo sapiens |
HDAC6 interactions in the central nervous system |
Homo sapiens |
PGK1, PKM2, KHKC/KHKA acting as protein kinases |
Homo sapiens |
ACE inhibitor pathway |
Homo sapiens |
Amyotrophic lateral sclerosis (ALS) |
Homo sapiens |
Bladder cancer |
Homo sapiens |
TCA cycle nutrient use and invasiveness of ovarian cancer |
Homo sapiens |
SIDS susceptibility pathways |
Bos taurus |
Copper homeostasis |
Homo sapiens |
FTO obesity variant mechanism |
Homo sapiens |
Striated muscle contraction pathway |
Homo sapiens |
4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression |
Homo sapiens |
Endometrial cancer |
Homo sapiens |
Breast cancer pathway |
Homo sapiens |
Lamin A processing pathway |
Homo sapiens |
miRNA role in immune response in sepsis |
Homo sapiens |
LTF danger signal response pathway |
Homo sapiens |
Modified nucleosides derived from tRNA as urinary cancer markers |
Homo sapiens |
Pathways of nucleic acid metabolism and innate immune sensing |
Homo sapiens |
Kinin-Kallikrein pathway |
Homo sapiens |
Cholesterol synthesis disorders |
Homo sapiens |
Alstrom syndrome |
Homo sapiens |
Thyroid hormone imbalance leading to neurodevelopmental abnormalities |
Homo sapiens |
Genetic causes of porto-sinusoidal vascular disease |
Homo sapiens |
Steroid hormone precursor biosynthesis |
Homo sapiens |
Cytokines and inflammatory response |
Homo sapiens |
JAK-STAT signaling in the regulation of beta cells |
Homo sapiens |
Focal adhesion |
Mus musculus |
Wnt signaling pathway |
Danio rerio |
Codeine and morphine metabolism |
Homo sapiens |
Polycystic kidney disease pathway |
Homo sapiens |
Drug induction of bile acid pathway |
Bos taurus |
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer |
Homo sapiens |
Neovascularization processes |
Homo sapiens |
Urea cycle and related diseases |
Homo sapiens |
Leucine, isoleucine and valine metabolism |
Homo sapiens |
FGFR3 signaling in chondrocyte proliferation and terminal differentiation |
Homo sapiens |
Linoleic acid metabolism affected by SARS-CoV-2 |
Homo sapiens |
Angiotensin II receptor type 1 pathway |
Homo sapiens |
T cell modulation in pancreatic cancer |
Homo sapiens |
Calcium mediated T-cell apoptosis involved in inclusion body myositis |
Homo sapiens |
Arsenic liver toxicity pathway |
Homo sapiens |
Abnormal calcium handling and its effects on muscle contraction in DMD |
Homo sapiens |
15q25 copy number variation |
Homo sapiens |
GLP-1 secretion from intestine to portal vein |
Homo sapiens |
Glutamate degradation I |
Saccharomyces cerevisiae |
Sulfate assimilation pathway II |
Saccharomyces cerevisiae |
Estrogen signaling pathway |
Homo sapiens |
Metastatic brain tumor |
Homo sapiens |
Spinal cord injury |
Homo sapiens |
Sulindac metabolic pathway |
Homo sapiens |
Blood clotting cascade |
Homo sapiens |
NRF2 pathway |
Homo sapiens |
Interactome of polycomb repressive complex 2 (PRC2) |
Homo sapiens |
Focal adhesion |
Homo sapiens |
Photodynamic therapy-induced unfolded protein response |
Homo sapiens |
Gut-liver indole metabolism |
Homo sapiens |
Hfe effect on hepcidin production |
Homo sapiens |
TYROBP causal network in microglia |
Homo sapiens |
Splicing factor NOVA regulated synaptic proteins |
Homo sapiens |
MAPK cascade |
Homo sapiens |
Male infertility |
Homo sapiens |
Glycerolipids and glycerophospholipids |
Homo sapiens |
Neuroinflammation and glutamatergic signaling |
Homo sapiens |
Opioid receptor pathways |
Homo sapiens |
Network map of SARS-CoV-2 signaling pathway |
Homo sapiens |
SARS-CoV-2 replication organelle formation |
Homo sapiens |
Amino acid conjugation of benzoic acid |
Homo sapiens |
2q11.2 copy number variation syndrome |
Homo sapiens |
Mitochondrial beta-oxidation |
Homo sapiens |
TGFβ/Smad signaling pathway |
Homo sapiens |
ErbB signaling pathway |
Homo sapiens |
Arachidonate epoxygenase / epoxide hydrolase |
Homo sapiens |
Serotonin HTR1 group and FOS pathway |
Homo sapiens |
Serotonin receptor 4/6/7 and NR3C signaling |
Homo sapiens |
Energy metabolism |
Homo sapiens |
Tryptophan catabolism leading to NAD+ production |
Homo sapiens |
Mitochondrial complex I assembly model OXPHOS system |
Homo sapiens |
Vitamin D in inflammatory diseases |
Homo sapiens |
GPCRs, class A rhodopsin-like |
Homo sapiens |
Eicosanoid metabolism via cyclooxygenases (COX) |
Homo sapiens |
Host-pathogen interaction of human coronaviruses - autophagy |
Homo sapiens |
Airway smooth muscle cell contraction |
Homo sapiens |
Kallmann syndrome |
Homo sapiens |
Orexin receptor pathway |
Homo sapiens |
Sphingolipid metabolism in senescence |
Homo sapiens |
Vitamin K metabolism and activation of dependent proteins |
Homo sapiens |
Metabolic reprogramming in pancreatic cancer |
Homo sapiens |
Glycosphingolipid metabolism |
Homo sapiens |
Octadecanoid formation from linoleic acid |
Homo sapiens |
TGF-beta receptor signaling |
Homo sapiens |
Nicotine effect on chromaffin cells |
Homo sapiens |
Cell cycle |
Homo sapiens |
Integrated cancer pathway |
Homo sapiens |
Follicle stimulating hormone (FSH) signaling pathway |
Homo sapiens |
Microtubule cytoskeleton regulation |
Homo sapiens |
Deregulation of Rab and Rab effector genes in bladder cancer |
Homo sapiens |
AGE/RAGE pathway |
Homo sapiens |
Allograft rejection |
Homo sapiens |
Oncostatin M signaling pathway |
Homo sapiens |
Apoptosis-related network due to altered Notch3 in ovarian cancer |
Homo sapiens |
Constitutive androstane receptor pathway |
Homo sapiens |
PPAR-alpha pathway |
Homo sapiens |
Interactions between LOXL4 and oxidative stress pathway |
Homo sapiens |
Prader-Willi and Angelman syndrome |
Homo sapiens |
Exercise-induced circadian regulation |
Homo sapiens |
Mevalonate arm of cholesterol biosynthesis pathway |
Homo sapiens |
Phosphodiesterases in neuronal function |
Homo sapiens |
EGF/EGFR signaling pathway |
Homo sapiens |
Biomarkers for urea cycle disorders |
Homo sapiens |
Renin-angiotensin-aldosterone system (RAAS) |
Homo sapiens |
Somatic sex determination |
Homo sapiens |
Genes controlling nephrogenesis |
Homo sapiens |
7q11.23 copy number variation syndrome |
Homo sapiens |
Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins |
Homo sapiens |
Biotin metabolism, including IMDs |
Homo sapiens |
Burn wound healing |
Homo sapiens |
2q21.1 copy number variation syndrome |
Homo sapiens |
G13 signaling pathway |
Homo sapiens |
Tamoxifen metabolism |
Homo sapiens |
Monoamine transport |
Homo sapiens |
Valine, leucine and isoleucine degradation |
Caenorhabditis elegans |
Apoptosis modulation and signaling |
Homo sapiens |
Pilocytic astrocytoma |
Homo sapiens |
Selenium metabolism and selenoproteins |
Homo sapiens |
Regulation of apoptosis by parathyroid hormone-related protein |
Homo sapiens |
Angiopoietin-like protein 8 regulatory pathway |
Homo sapiens |
Embryonic stem cell pluripotency pathways |
Homo sapiens |
Focal adhesion: PI3K-Akt-mTOR-signaling pathway |
Homo sapiens |
Serotonin and anxiety |
Homo sapiens |
Tyrosine metabolism and related disorders |
Homo sapiens |
Inflammatory response pathway |
Homo sapiens |
Proteoglycan biosynthesis |
Homo sapiens |
Type I collagen synthesis in the context of osteogenesis imperfecta |
Homo sapiens |
Multiple epiphyseal dysplasia and pseudoachondroplasia genes |
Homo sapiens |
Mitochondrial complex inhibition leading to liver injury |
Homo sapiens |
Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway) |
Homo sapiens |
Immune infiltration in pancreatic cancer |
Homo sapiens |
Enterohepatic circulation of bile acids |
Homo sapiens |
Mammary gland development pathway - Involution (Stage 4 of 4) |
Homo sapiens |
Development of pulmonary dendritic cells and macrophage subsets |
Homo sapiens |
Rett syndrome |
Homo sapiens |
Altered glycosylation of MUC1 in tumor microenvironment |
Homo sapiens |
IL-10 anti-inflammatory signaling pathway |
Homo sapiens |
Molybdenum cofactor (Moco) biosynthesis |
Homo sapiens |
Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway |
Homo sapiens |
Somitogenesis in the context of spondylocostal dysostosis |
Homo sapiens |
Cholesterol biosynthesis with skeletal dysplasias |
Homo sapiens |
3q29 copy number variation syndrome |
Homo sapiens |
Prostaglandin signaling |
Homo sapiens |
SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome |
Homo sapiens |
Cardiomyocyte signaling pathways converging on titin |
Homo sapiens |
10q11.21q11.23 copy number variation syndrome |
Homo sapiens |
15q11q13 copy number variation |
Homo sapiens |
Artemisinin inhibition of uveal melanoma |
Homo sapiens |
GLP-1 in pancreatic islet cells |
Homo sapiens |
Phase I biotransformations, non-P450 |
Rattus norvegicus |
G protein signaling pathways |
Homo sapiens |
Wnt myofibroblastic activation of hepatic stellate cells |
Rattus norvegicus |
Ectodysplasin A signaling in hair follicle development |
Mus musculus |
Dysregulated miRNA targeting in insulin/PI3K-AKT signaling |
Mus musculus |
Purine metabolism and related disorders |
Homo sapiens |
Disorders of folate metabolism and transport |
Homo sapiens |
Selective expression of chemokine receptors during T-cell polarization |
Homo sapiens |
Melanoma |
Homo sapiens |
Autosomal recessive osteopetrosis pathways |
Homo sapiens |
Adverse outcome pathway for mitochondrial complex 1 (C1) inhibition |
Homo sapiens |
Mitochondrial immune response to SARS-CoV-2 |
Homo sapiens |
T-cell activation SARS-CoV-2 |
Homo sapiens |
Wnt/Beta-catenin signaling inhibitors in current and past clinical trials |
Homo sapiens |
Acetaminophen in analgesia and antipyresis |
Homo sapiens |
Glutamate degradation VII |
Saccharomyces cerevisiae |
Glutamate degradation VIII |
Saccharomyces cerevisiae |
Aryl hydrocarbon receptor pathway |
Homo sapiens |
Ebstein-Barr virus LMP1 signaling |
Homo sapiens |
Aripiprazole metabolic pathway |
Homo sapiens |
Notch signaling |
Homo sapiens |
Cardiac hypertrophic response |
Homo sapiens |
miR-517 relationship with ARCN1 and USP1 |
Homo sapiens |
Lung fibrosis |
Homo sapiens |
Insulin signaling in adipocytes (normal condition) |
Homo sapiens |
Physico-chemical features and toxicity-associated pathways |
Homo sapiens |
MAPK and NFkB signaling pathways inhibited by Yersinia YopJ |
Homo sapiens |
Toll-like receptor signaling related to MyD88 |
Homo sapiens |
Benzene metabolism |
Homo sapiens |
Eukaryotic transcription initiation |
Homo sapiens |
Hormonal control of pubertal growth spurt |
Homo sapiens |
Ras signaling |
Homo sapiens |
Regulatory circuits of the STAT3 signaling pathway |
Homo sapiens |
Neural crest cell migration in cancer |
Homo sapiens |
Purine metabolism |
Homo sapiens |
Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex |
Homo sapiens |
COVID-19 adverse outcome pathway |
Homo sapiens |
15q13.3 copy number variation syndrome |
Homo sapiens |
FOXA2 pathway |
Homo sapiens |
Female steroid hormones in cardiomyocyte energy metabolism |
Homo sapiens |
TAR syndrome |
Homo sapiens |
Complement and coagulation cascades |
Homo sapiens |
EPO receptor signaling |
Homo sapiens |
GPCRs, other |
Homo sapiens |
Sphingolipid pathway |
Homo sapiens |
Nucleotide-binding oligomerization domain (NOD) pathway |
Homo sapiens |
Sleep regulation |
Homo sapiens |
Circadian rhythm genes |
Homo sapiens |
mir-124 predicted interactions with cell cycle and differentiation |
Homo sapiens |
Apoptosis modulation by HSP70 |
Homo sapiens |
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling |
Homo sapiens |
Robo4 and VEGF signaling pathways crosstalk |
Homo sapiens |
Hereditary leiomyomatosis and renal cell carcinoma pathway |
Homo sapiens |
Pancreatic adenocarcinoma pathway |
Homo sapiens |
Non-genomic actions of 1,25 dihydroxyvitamin D3 |
Homo sapiens |
Non-homologous end joining |
Homo sapiens |
Omega-3 / omega-6 fatty acid synthesis |
Homo sapiens |
Intracellular trafficking proteins involved in CMT neuropathy |
Homo sapiens |
CAMKK2 pathway |
Homo sapiens |
SARS-CoV-2 and ACE2 receptor: molecular mechanisms |
Homo sapiens |
Phosphoinositides metabolism |
Homo sapiens |
Overview of proinflammatory and profibrotic mediators |
Homo sapiens |
Arachidonic acid (AA, ARA) oxylipin metabolism |
Homo sapiens |
DYRK1A involvement regarding cell proliferation in brain development |
Homo sapiens |
Acute myeloid leukemia |
Homo sapiens |
Sildenafil treatment |
Homo sapiens |
Ganglio series sphingolipid metabolism |
Homo sapiens |
DNA mismatch repair |
Homo sapiens |
Enterocyte cholesterol metabolism |
Homo sapiens |
T-cell receptor signaling pathway |
Homo sapiens |
Methylation pathways |
Homo sapiens |
Matrix metalloproteinases |
Homo sapiens |
Osteopontin signaling |
Homo sapiens |
miRNAs involved in DNA damage response |
Homo sapiens |
NAD biosynthesis II (from tryptophan) |
Homo sapiens |
Diclofenac metabolic pathway |
Homo sapiens |
Hair follicle development: cytodifferentiation - part 3 of 3 |
Homo sapiens |
Differentiation of white and brown adipocyte |
Homo sapiens |
Fas ligand pathway and stress induction of heat shock proteins |
Homo sapiens |
RAC1/PAK1/p38/MMP2 pathway |
Homo sapiens |
PPAR signaling pathway |
Homo sapiens |
Pyrimidine metabolism |
Homo sapiens |
Somatroph axis (GH) and its relationship to dietary restriction and aging |
Homo sapiens |
FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma |
Homo sapiens |
Gastrin signaling pathway |
Homo sapiens |
mBDNF and proBDNF regulation of GABA neurotransmission |
Homo sapiens |
Hijack of ubiquitination by SARS-CoV-2 |
Homo sapiens |
Proximal tubule transport |
Homo sapiens |
Autophagy |
Homo sapiens |
Nitric oxide metabolism in cystic fibrosis |
Homo sapiens |
Modulators of TCR signaling and T cell activation |
Homo sapiens |
Soluble ACE2-mediated cell entry of SARS-CoV-2 |
Homo sapiens |
Complement system in neuronal development and plasticity |
Homo sapiens |
Familial hyperlipidemia type 3 |
Homo sapiens |
Non-classical role of vitamin D |
Homo sapiens |
Vitamin A1 and A5/X pathways |
Homo sapiens |
Folate metabolism |
Homo sapiens |
TNF-related weak inducer of apoptosis (TWEAK) signaling pathway |
Homo sapiens |
Endothelin pathways |
Homo sapiens |
Thymic stromal lymphopoietin (TSLP) signaling pathway |
Homo sapiens |
Oxytocin signaling |
Homo sapiens |
IL-4 signaling pathway |
Homo sapiens |
Oligodendrocyte specification and differentiation, leading to myelin components for CNS |
Homo sapiens |
Signal transduction through IL1R |
Homo sapiens |
Intraflagellar transport proteins binding to dynein |
Homo sapiens |
Cytoplasmic ribosomal proteins |
Homo sapiens |
nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell |
Homo sapiens |
Linoleic acid oxylipin metabolism |
Homo sapiens |
Biosynthesis and turnover of 1-deoxy-sphingoid bases |
Homo sapiens |
Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution |
Homo sapiens |
PtdIns(4,5)P2 in cytokinesis pathway |
Homo sapiens |
Dravet syndrome |
Homo sapiens |
Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists |
Homo sapiens |
11p11.2 copy number variation syndrome |
Homo sapiens |
Synthesis and degradation of ketone bodies |
Drosophila melanogaster |
Homologous recombination |
Drosophila melanogaster |
Irinotecan pathway |
Rattus norvegicus |
Biogenic amine synthesis |
Drosophila melanogaster |
Glucuronidation |
Rattus norvegicus |
Transcriptional activation by Nfe2l2 in response to phytochemicals |
Rattus norvegicus |
Methylation |
Rattus norvegicus |
Selenium metabolism selenoproteins |
Rattus norvegicus |
Mismatch repair |
Rattus norvegicus |
Aflatoxin B1 metabolism |
Rattus norvegicus |
Mitochondrial gene expression |
Rattus norvegicus |
Estrogen metabolism |
Rattus norvegicus |
Polyol pathway |
Rattus norvegicus |
S1P receptor signal transduction |
Rattus norvegicus |
Peptide GPCRs |
Rattus norvegicus |
Fatty acid omega-oxidation |
Rattus norvegicus |
mRNA processing |
Drosophila melanogaster |
Statin pathway |
Rattus norvegicus |
Response regulator aspartate phosphatase interactions |
Bacillus subtilis |
Carbon assimilation C4 pathway |
Zea mays |
Adipogenesis |
Rattus norvegicus |
Glycogen metabolism |
Rattus norvegicus |
Small ligand GPCRs |
Rattus norvegicus |
Eukaryotic transcription initiation |
Drosophila melanogaster |
VEGFR-3 signaling |
Rattus norvegicus |
VEGF-receptor signal transduction |
Rattus norvegicus |
Thyroxine (thyroid hormone) production |
Homo sapiens |
Prolactin signaling pathway |
Homo sapiens |
Notch signaling pathway |
Drosophila melanogaster |
Brain derived neurotrophic factor |
Rattus norvegicus |
Lycopene biosynthesis |
Zea mays |
Carotenoid biosynthesis |
Zea mays |
Osteoblast signaling |
Rattus norvegicus |
RalA downstream regulated genes |
Homo sapiens |
Vitamin B9 (folate) biosynthesis pathway |
Zea mays |
Folate biosynthesis |
Bacillus subtilis |
Brain-derived neurotrophic factor (BDNF) signaling pathway |
Homo sapiens |
Fatty acid beta-oxidation 3 |
Drosophila melanogaster |
Heme biosynthesis |
Drosophila melanogaster |
mir219 in oligodendrocyte differentiation and myelination |
Rattus norvegicus |
Proteasome degradation |
Drosophila melanogaster |
p38 Mapk signaling pathway |
Rattus norvegicus |
Proteasome degradation |
Rattus norvegicus |
Prostaglandin synthesis and regulation |
Rattus norvegicus |
MFAP5-mediated ovarian cancer cell motility and invasiveness |
Homo sapiens |
TCA cycle |
Rattus norvegicus |
Synthesis and degradation of ketone bodies |
Rattus norvegicus |
Photodynamic therapy-induced AP-1 survival signaling |
Homo sapiens |
Acetate mediated promotion of metabolic syndrome |
Rattus norvegicus |
Equilibrium signaling pathway of differentiated cells |
Drosophila melanogaster |
Humoral immune response to fungal and bacterial pathogens |
Drosophila melanogaster |
Beta-oxidation meta-pathway |
Rattus norvegicus |
Wnt signaling pathway |
Rattus norvegicus |
GPCRs, class B secretin-like |
Rattus norvegicus |
Toll, IMD, JAK/STAT pathways for immune response to pathogens |
Drosophila melanogaster |
Cannabinoid receptor signaling |
Homo sapiens |
Thick ascending limb transporters |
Rattus norvegicus |
Angiotensin II signaling (acute) in thick ascending limbs |
Rattus norvegicus |
Lipid droplet metabolism |
Rattus norvegicus |
Hexoses metabolism in proximal tubules |
Rattus norvegicus |
miR-509-3p alteration of YAP1/ECM axis |
Homo sapiens |
ID signaling pathway |
Rattus norvegicus |
Fatty acid beta-oxidation 1 |
Drosophila melanogaster |
Mitochondrial long chain fatty acid beta-oxidation |
Drosophila melanogaster |
GPCRs, other |
Rattus norvegicus |
Beta-oxidation of unsaturated fatty acids |
Rattus norvegicus |
Mitochondrial fatty acid synthesis pathway |
Homo sapiens |
Insulin signaling |
Rattus norvegicus |
IL-5 signaling pathway |
Rattus norvegicus |
Head and neck squamous cell carcinoma |
Homo sapiens |
Base excision repair |
Homo sapiens |
Apoptosis modulation by HSP70 |
Rattus norvegicus |
Hedgehog signaling pathway |
Drosophila melanogaster |
Burn wound healing |
Rattus norvegicus |
Familial hyperlipidemia type 5 |
Homo sapiens |
Leukotriene metabolic pathway |
Homo sapiens |
G13 signaling pathway |
Rattus norvegicus |
Cholesterol metabolism |
Homo sapiens |
Translation factors |
Drosophila melanogaster |
Biosynthesis of anthocyanins from phenylalanine in purple corn |
Zea mays |
Biogenic amine synthesis |
Homo sapiens |
DNA replication |
Drosophila melanogaster |
Fatty acid biosynthesis |
Drosophila melanogaster |
Type II interferon signaling |
Homo sapiens |
Steroid biosynthesis |
Rattus norvegicus |
G protein signaling pathways |
Rattus norvegicus |
Integrin-mediated cell adhesion |
Rattus norvegicus |
Heme biosynthesis |
Rattus norvegicus |
Hepatocyte growth factor receptor signaling |
Rattus norvegicus |
Wnt signaling pathway |
Drosophila melanogaster |
IL-1 signaling pathway |
Homo sapiens |
Corticotropin-releasing hormone signaling pathway |
Homo sapiens |
HIF1A and PPARG regulation of glycolysis |
Homo sapiens |
Primary focal segmental glomerulosclerosis (FSGS) |
Homo sapiens |
Interleukin-1 (IL-1) structural pathway |
Homo sapiens |
Glucocorticoid receptor pathway |
Homo sapiens |
Hepatocyte growth factor receptor signaling |
Homo sapiens |
Melatonin metabolism and effects |
Homo sapiens |
Dual hijack model of Vif in HIV infection |
Homo sapiens |
Zinc homeostasis |
Homo sapiens |
Fatty acid biosynthesis |
Homo sapiens |
Pathways affected in adenoid cystic carcinoma |
Homo sapiens |
Valproic acid pathway |
Homo sapiens |
Mitochondrial gene expression |
Homo sapiens |
Leptin-insulin signaling overlap |
Homo sapiens |
mRNA, protein, and metabolite inducation pathway by cyclosporin A |
Homo sapiens |
Transcriptional activation by NRF2 in response to phytochemicals |
Homo sapiens |
Clear cell renal cell carcinoma pathways |
Homo sapiens |
Phosphatidylcholine catabolism |
Homo sapiens |
Resistin as a regulator of inflammation |
Homo sapiens |
Role of carnosine in muscle contraction |
Homo sapiens |
MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement |
Homo sapiens |
Neural crest cell migration during development |
Homo sapiens |
Serine metabolism |
Homo sapiens |
Ketogenesis and ketolysis |
Homo sapiens |
Host-pathogen interaction of human coronaviruses - MAPK signaling |
Homo sapiens |
MAPK pathway in congenital thyroid cancer |
Homo sapiens |
Glycolysis in senescence |
Homo sapiens |
Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia |
Homo sapiens |
Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway |
Homo sapiens |
ALA oxylipin metabolism |
Homo sapiens |
Urotensin-II-mediated signaling pathway |
Homo sapiens |
COVID-19 and endothelial cell senescence |
Homo sapiens |
IL-26 signaling pathways |
Homo sapiens |
Kleefstra syndrome |
Homo sapiens |
NPHP1 deletion syndrome |
Homo sapiens |
IL-19 signaling pathway |
Homo sapiens |
Alanine and aspartate metabolism |
Homo sapiens |
MicroRNAs in cardiomyocyte hypertrophy |
Homo sapiens |
Nicotine metabolism in liver cells |
Homo sapiens |
Trans-sulfuration pathway |
Homo sapiens |
Cardiac progenitor differentiation |
Homo sapiens |
Ectoderm differentiation |
Homo sapiens |
Triacylglyceride synthesis |
Homo sapiens |
Joubert syndrome |
Homo sapiens |
Nucleotide excision repair |
Homo sapiens |
Insulin signaling |
Homo sapiens |
Regucalcin in proximal tubule epithelial kidney cells |
Homo sapiens |
Mammalian disorder of sexual development |
Homo sapiens |
Genes associated with the development of rheumatoid arthritis |
Homo sapiens |
Hypertrophy model |
Homo sapiens |
SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction |
Homo sapiens |
Lacto series sphingolipid metabolism |
Homo sapiens |
Prostaglandin synthesis and regulation |
Homo sapiens |
B cell receptor signaling pathway |
Homo sapiens |
Trans-sulfuration, one-carbon metabolism and related pathways |
Homo sapiens |
Liver X receptor pathway |
Homo sapiens |
Myometrial relaxation and contraction pathways |
Homo sapiens |
Kit receptor signaling pathway |
Homo sapiens |
Cytosine methylation |
Homo sapiens |
Lipid particles composition |
Homo sapiens |
Insulin signaling in adipocytes (diabetic condition) |
Homo sapiens |
Regulation of Wnt / B-catenin signaling by small molecule compounds |
Homo sapiens |
Development and heterogeneity of the ILC family |
Homo sapiens |
Ferroptosis |
Homo sapiens |
Major receptors targeted by epinephrine and norepinephrine |
Homo sapiens |
EGFR tyrosine kinase inhibitor resistance |
Homo sapiens |
Mitochondrial complex IV assembly |
Homo sapiens |
15q11.2 copy number variation syndrome |
Homo sapiens |
Deregulation of renin-angiotensin system by SARS-CoV infection |
Mus musculus |
Pentose phosphate pathway in senescent cells |
Homo sapiens |
NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence |
Homo sapiens |
TCA cycle in senescence |
Homo sapiens |
SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation |
Homo sapiens |
Sialylation |
Homo sapiens |
Synthesis of ceramides and 1-deoxyceramides |
Homo sapiens |
Arylamine metabolism |
Homo sapiens |
Benzo(a)pyrene metabolism |
Homo sapiens |
Gastric cancer network 1 |
Homo sapiens |
Lidocaine metabolism |
Homo sapiens |
eIF5A regulation in response to inhibition of the nuclear export system |
Homo sapiens |
Protein alkylation leading to liver fibrosis |
Homo sapiens |
Mevalonate arm of cholesterol biosynthesis pathway with inhibitors |
Homo sapiens |
Regulation of sister chromatid separation at the metaphase-anaphase transition |
Homo sapiens |
Cysteine and methionine catabolism |
Homo sapiens |
Amino acid metabolism pathway excerpt: histidine catabolism extension |
Homo sapiens |
Vitamin D-sensitive calcium signaling in depression |
Homo sapiens |
Eicosanoid metabolism via lipooxygenases (LOX) |
Homo sapiens |
Netrin-UNC5B signaling pathway |
Homo sapiens |
IL-18 signaling pathway |
Homo sapiens |
GPR143 in melanocytes and retinal pigment epithelium cells |
Homo sapiens |
Nephrogenesis |
Homo sapiens |
Fatty acid transporters |
Homo sapiens |
FOXP3 in COVID-19 |
Homo sapiens |
SARS-CoV-2 altering angiogenesis via NRP1 |
Homo sapiens |
Inclusion body myositis |
Homo sapiens |
Th17 cell differentiation pathway |
Homo sapiens |
GDNF signaling |
Homo sapiens |
Docosahexaenoic acid oxylipin metabolism |
Homo sapiens |
Cholestasis |
Homo sapiens |
Lac-Phe pathway |
Homo sapiens |
Neolacto series sphingolipid metabolism |
Homo sapiens |
Affected pathways in Duchenne muscular dystrophy |
Homo sapiens |
Glycosaminoglycan synthesis in fibroblasts |
Homo sapiens |
Cholesterol biosynthesis |
Mus musculus |
Hedgehog signaling pathway |
Mus musculus |
Glucuronidation |
Mus musculus |
Non-homologous end joining |
Mus musculus |
EBV LMP1 signaling |
Mus musculus |
Transcriptional activation by Nfe2l2 in response to phytochemicals |
Mus musculus |
Methylation |
Mus musculus |
EPO receptor signaling |
Mus musculus |
Amino acid conjugation of benzoic acid |
Mus musculus |
Nod-like receptor (NLR) signaling pathway |
Mus musculus |
ErbB signaling pathway |
Mus musculus |
Aflatoxin B1 metabolism |
Mus musculus |
Estrogen metabolism |
Mus musculus |
Fatty acid beta-oxidation |
Mus musculus |
Endochondral ossification |
Mus musculus |
GPCRs, non-odorant |
Mus musculus |
Regulation of cardiac hypertrophy by miR-208 |
Mus musculus |
MicroRNAs in cardiomyocyte hypertrophy |
Mus musculus |
Acetylcholine synthesis |
Mus musculus |
Mechanisms associated with pluripotency |
Mus musculus |
Splicing factor NOVA regulated synaptic proteins |
Mus musculus |
Neural crest differentiation |
Mus musculus |
Alzheimer's disease |
Mus musculus |
Nucleotide GPCRs |
Mus musculus |
SREBF and miR33 in cholesterol and lipid homeostasis |
Mus musculus |
Purine metabolism |
Mus musculus |
Chemokine signaling pathway |
Mus musculus |
Osteoblast signaling |
Mus musculus |
Spinal cord injury |
Mus musculus |
Mapk cascade |
Mus musculus |
Primary focal segmental glomerulosclerosis (FSGS) |
Mus musculus |
Delta-Notch signaling pathway |
Mus musculus |
p53 signaling |
Mus musculus |
Electron transport chain |
Mus musculus |
IL-7 signaling pathway |
Mus musculus |
Translation factors |
Mus musculus |
mRNA processing |
Mus musculus |
Glycogen metabolism |
Mus musculus |
GPCRs, class C metabotropic glutamate, pheromone |
Mus musculus |
GPCRs, small ligand |
Mus musculus |
Tyrobp causal network in microglia |
Mus musculus |
Lung fibrosis |
Mus musculus |
Novel Jun-Dmp1 pathway |
Mus musculus |
BMP signaling pathway in eyelid development |
Mus musculus |
IL-3 signaling pathway |
Mus musculus |
Prostaglandin synthesis and regulation |
Mus musculus |
Myometrial relaxation and contraction pathways |
Mus musculus |
Triacylglyceride synthesis |
Mus musculus |
mir-193a and MVP in colon cancer metastasis |
Mus musculus |
Oxidative stress response |
Mus musculus |
Distal convoluted tubule 1 (DCT1) cell |
Mus musculus |
Ethanol metabolism resulting in production of ROS by CYP2E1 |
Mus musculus |
Nuclear receptors in lipid metabolism and toxicity |
Mus musculus |
Eicosanoid lipid synthesis map |
Mus musculus |
Sphingolipid metabolism overview |
Mus musculus |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
Mus musculus |
Eicosanoid metabolism via cyclooxygenases (COX) |
Mus musculus |
Eicosanoid metabolism via lipoxygenases (LOX) |
Mus musculus |
Eicosanoid metabolism via cytochrome P450 monooxygenases |
Mus musculus |
TCA cycle |
Mus musculus |
Omega-3 / omega-6 fatty acid synthesis |
Mus musculus |
One-carbon metabolism |
Mus musculus |
Oxidative stress and redox pathway |
Mus musculus |
Circulating monocytes and cardiac macrophages in diastolic dysfunction |
Mus musculus |
Inflammatory response pathway |
Mus musculus |
Blood clotting cascade |
Mus musculus |
Peroxiredoxin 2 induced ovarian failure |
Mus musculus |
Proteasome degradation |
Mus musculus |
Regulation of actin cytoskeleton |
Mus musculus |
Comprehensive IL-17A signaling |
Mus musculus |
Synthesis and degradation of ketone bodies |
Mus musculus |
Exercise-induced circadian regulation |
Mus musculus |
Eukaryotic transcription initiation |
Mus musculus |
Monoamine GPCRs |
Mus musculus |
FAS pathway and stress induction of HSP regulation |
Mus musculus |
EGFR1 signaling pathway |
Mus musculus |
Signal transduction of S1P receptor |
Mus musculus |
Wnt signaling pathway and pluripotency |
Mus musculus |
Toll-like receptor signaling |
Mus musculus |
Intracellular auxin transport |
Arabidopsis thaliana |
Amplification and expansion of oncogenic pathways as metastatic traits |
Homo sapiens |
Dengue-2 interactions with complement and coagulation cascades |
Homo sapiens |
G1 to S cell cycle control |
Homo sapiens |
SARS-CoV-2 and COVID-19 pathway |
Homo sapiens |
TCA cycle (aka Krebs or citric acid cycle) |
Homo sapiens |
Irinotecan pathway |
Bos taurus |
Phase I biotransformations, non-P450 |
Equus caballus |
Glial cell differentiation |
Homo sapiens |
Thyroid hormones production and peripheral downstream signaling effects |
Homo sapiens |
Cellular proteostasis |
Homo sapiens |
Lung pathology of COVID-19 |
Homo sapiens |
Lipid remodeling |
Anopheles gambiae |
FGFR4 p.G388R signaling pathway |
Homo sapiens |
FLT3 p.Gln640SerfsTer8 signaling pathway |
Homo sapiens |
Androgen receptor signaling pathway |
Homo sapiens |
Genes targeted by miRNAs in adipocytes |
Homo sapiens |
Nanoparticle triggered autophagic cell death |
Homo sapiens |
Pluripotent stem cell differentiation pathway |
Homo sapiens |
Pregnane X receptor pathway |
Homo sapiens |
Estrogen receptor pathway |
Homo sapiens |
DNA IR-double strand breaks and cellular response via ATM |
Homo sapiens |
Fibrin complement receptor 3 signaling pathway |
Homo sapiens |
Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells |
Homo sapiens |
Cells and molecules involved in local acute inflammatory response |
Homo sapiens |
Interactions between immune cells and microRNAs in tumor microenvironment |
Homo sapiens |
Hepatitis B infection |
Homo sapiens |
Glycogen synthesis and degradation |
Homo sapiens |
Pleural mesothelioma |
Homo sapiens |
Nucleotide excision repair in xeroderma pigmentosum |
Homo sapiens |
Arsenic metabolism and reactive oxygen species generation |
Homo sapiens |
Neurogenesis regulation in the olfactory epithelium |
Homo sapiens |
Mineralocorticoid biosynthesis |
Homo sapiens |
1p36 copy number variation syndrome |
Homo sapiens |
Calcium regulation in cardiac cells |
Homo sapiens |
PAFAH1B1 copy number variation |
Homo sapiens |
Sulfation biotransformation reaction |
Homo sapiens |
Influenza A virus infection |
Homo sapiens |
Serotonin transporter activity |
Homo sapiens |
Osteoblast signaling |
Homo sapiens |
Metabolism overview |
Homo sapiens |
Novel intracellular components of RIG-I-like receptor pathway |
Homo sapiens |
Thermogenesis |
Homo sapiens |
Nonalcoholic fatty liver disease |
Homo sapiens |
Blood clotting and drug effects |
Homo sapiens |
Purinergic signaling |
Homo sapiens |
Galanin receptor pathway |
Homo sapiens |
6q16 copy number variation |
Homo sapiens |
Amino acid conjugation |
Homo sapiens |
Fatty acid beta-oxidation |
Homo sapiens |
Fluoropyrimidine activity |
Homo sapiens |
Homologous recombination |
Homo sapiens |
IL-17 signaling pathway |
Homo sapiens |
Retinoblastoma gene in cancer |
Homo sapiens |
Alpha 6 beta 4 signaling pathway |
Homo sapiens |
Mesodermal commitment pathway |
Homo sapiens |
Metabolism of dichloroethylene by CYP450 |
Homo sapiens |
VEGFA-VEGFR2 signaling |
Homo sapiens |
ApoE and miR-146 in inflammation and atherosclerosis |
Homo sapiens |
BMP signaling in eyelid development |
Homo sapiens |
Leptin and adiponectin |
Homo sapiens |
White fat cell differentiation |
Homo sapiens |
Transcriptional cascade regulating adipogenesis |
Homo sapiens |
Flavan-3-ol metabolic pathway |
Homo sapiens |
Peroxiredoxin 2 induced ovarian failure |
Homo sapiens |
LDLRAD4 and what we know about it |
Homo sapiens |
SARS coronavirus and innate immunity |
Homo sapiens |
Neuroinflammation |
Homo sapiens |
Mitochondrial complex II assembly |
Homo sapiens |
Mitochondrial complex III assembly |
Homo sapiens |
COVID-19, thrombosis and anticoagulation |
Homo sapiens |
Mitochondrial complex I inhibition leading to parkinsonian motor deficits |
Homo sapiens |
Lipid metabolism in senescent cells |
Homo sapiens |
TROP2 regulatory signaling |
Homo sapiens |
5q35 copy number variation |
Homo sapiens |
Phosphatidyl inositol phosphate pathway |
Homo sapiens |
Aflatoxin B1 metabolism |
Homo sapiens |
IL-5 signaling pathway |
Homo sapiens |
Peroxisomal beta-oxidation of tetracosanoyl-CoA |
Homo sapiens |
Cell differentiation - index |
Homo sapiens |
Common pathways underlying drug addiction |
Homo sapiens |
Mevalonate pathway |
Homo sapiens |
PDGFR-beta pathway |
Homo sapiens |
p38 MAPK signaling pathway |
Homo sapiens |
NRF2-ARE regulation |
Homo sapiens |
Synaptic signaling pathways associated with autism spectrum disorder |
Homo sapiens |
Type I interferon induction and signaling during SARS-CoV-2 infection |
Homo sapiens |
Direct reversal repair |
Homo sapiens |
Frustrated phagocytosis leading to malignant pleural mesothelioma |
Homo sapiens |
CCL18 signaling pathway |
Homo sapiens |
Progeria-associated lipodystrophy |
Homo sapiens |
Familial hyperlipidemia type 2 |
Homo sapiens |
COVID-19 structural coverage map |
Homo sapiens |
Pro-survival signaling of neuroprotectin D1 |
Homo sapiens |
Sulfatase and aromatase pathway |
Homo sapiens |
Heme biosynthesis |
Homo sapiens |
Non-homologous end joining |
Rattus norvegicus |
EBV LMP1 signaling |
Rattus norvegicus |
Estrogen signaling |
Rattus norvegicus |
Hypothetical network for drug addiction |
Rattus norvegicus |
Oxidative phosphorylation |
Rattus norvegicus |
EPO receptor signaling |
Rattus norvegicus |
Metapathway biotransformation |
Rattus norvegicus |
Amino acid conjugation of benzoic acid |
Rattus norvegicus |
Wnt signaling pathway and pluripotency |
Rattus norvegicus |
Type II interferon signaling (IFNG) |
Rattus norvegicus |
Apoptosis |
Rattus norvegicus |
Nod-like receptor (NLR) signaling pathway |
Rattus norvegicus |
Homologous recombination |
Rattus norvegicus |
Retinol metabolism |
Rattus norvegicus |
ErbB signaling pathway |
Rattus norvegicus |
Toll-like receptor signaling pathway |
Rattus norvegicus |
Selenium micronutrient network |
Rattus norvegicus |
Folic acid network |
Rattus norvegicus |
Nuclear receptors in lipid metabolism and toxicity |
Rattus norvegicus |
Myometrial relaxation and contraction pathways |
Rattus norvegicus |
Photosynthetic carbon reduction |
Arabidopsis thaliana |
Nucleotide metabolism |
Rattus norvegicus |
Kit receptor signaling pathway |
Rattus norvegicus |
Interactions between CFTR and other ion channels |
Rattus norvegicus |
Intracellular trafficking of CFTR |
Rattus norvegicus |
TNF-alpha and mucus production in lung epythelium |
Rattus norvegicus |
CFTR activity in the plasma membrane |
Rattus norvegicus |
Translation factors |
Rattus norvegicus |
Flavonoid biosynthesis |
Arabidopsis thaliana |
Oxidative stress response |
Rattus norvegicus |
Focal adhesion |
Rattus norvegicus |
Glucocorticoid effect on target gene expression |
Rattus norvegicus |
Genetic alterations of lung cancer |
Rattus norvegicus |
Linoleate biosynthesis |
Arabidopsis thaliana |
Flower development: initiation |
Arabidopsis thaliana |
Serotonin and anxiety |
Rattus norvegicus |
Nuclear receptors |
Rattus norvegicus |
Chlorophyll b degradation |
Arabidopsis thaliana |
Seed development |
Arabidopsis thaliana |
Nuclear factor, erythroid-derived 2, like 2 signaling pathway |
Rattus norvegicus |
Spinal cord injury |
Rattus norvegicus |
Sulindac metabolic pathway |
Rattus norvegicus |
Relationship between glutathione and NADPH |
Rattus norvegicus |
Cadmium and glutathione |
Arabidopsis thaliana |
Glycolysis |
Arabidopsis thaliana |
Starch metabolism |
Arabidopsis thaliana |
Sucrose metabolism |
Arabidopsis thaliana |
TCA cycle (Krebs cycle) |
Arabidopsis thaliana |
Brassinolide biosynthetic pathway |
Arabidopsis thaliana |
Tryptophan metabolism |
Rattus norvegicus |
Monoamine GPCRs |
Rattus norvegicus |
Matrix metalloproteinases |
Rattus norvegicus |
Pentose phosphate pathway |
Rattus norvegicus |
Ethylene signaling pathway |
Arabidopsis thaliana |
Polar auxin transport |
Arabidopsis thaliana |
Cytokinin signaling |
Arabidopsis thaliana |
Cytokinin-auxin interactions in plant development |
Arabidopsis thaliana |
UDP-L-arabinose biosynthesis I from UDP-xylose |
Arabidopsis thaliana |
Glucocorticoid metabolism |
Rattus norvegicus |
Striated muscle contraction |
Rattus norvegicus |
IL-3 signaling pathway |
Rattus norvegicus |
G1 to S cell cycle control |
Rattus norvegicus |
Regulation of actin cytoskeleton |
Rattus norvegicus |
IL-1 signaling pathway |
Rattus norvegicus |
MAPK signaling pathway |
Rattus norvegicus |
Acetylcholine synthesis |
Rattus norvegicus |
Flavonoid pathway |
Arabidopsis thaliana |
AtMetExpress overview |
Arabidopsis thaliana |
Genetic interactions between sugar and hormone signaling |
Arabidopsis thaliana |
Phytochrome signaling pathway to turn on photomorphogenesis |
Arabidopsis thaliana |
Renin-angiotensin system |
Rattus norvegicus |
Glucose sensing and signaling |
Arabidopsis thaliana |
Proximal tubule transporters |
Rattus norvegicus |
Fructose metabolism in proximal tubules |
Rattus norvegicus |
Insulin induced PI3K-Akt and MAPK in hepatocytes |
Rattus norvegicus |
Biosynthesis of gamma-aminobutyric acid (GABA) by polyamine oxidation |
Arabidopsis thaliana |
Hypertrophy model |
Rattus norvegicus |
Vanillin and isovanillin metabolism |
Rattus norvegicus |
TNF-alpha NF-kB signaling pathway |
Rattus norvegicus |
Glucosinolate biosynthesis from methionine |
Arabidopsis thaliana |
Glucosinolate biosynthesis (from aromatic amino acid) |
Arabidopsis thaliana |
Glucosinolate biosynthesis from branched-chain amino acid |
Arabidopsis thaliana |
Glutathione metabolism |
Rattus norvegicus |
GPCRs, class A rhodopsin-like |
Rattus norvegicus |
Osteoclast |
Rattus norvegicus |
Nucleotide GPCRs |
Rattus norvegicus |
Fatty acid biosynthesis |
Rattus norvegicus |
Biosynthesis of aldosterone and cortisol |
Rattus norvegicus |
Catecholamine synthesis |
Rattus norvegicus |
Notch signaling pathway |
Rattus norvegicus |
mRNA processing |
Rattus norvegicus |
Globo series sphingolipid metabolism |
Mus musculus |
Representative anthocyanin biosynthetic pathway |
Arabidopsis thaliana |
CBD synthetic pathway |
Arabidopsis thaliana |
Complement and coagulation cascades |
Rattus norvegicus |
Calcium regulation in cardiac cells |
Mus musculus |
ACE inhibitor pathway |
Rattus norvegicus |
IL-2 signaling pathway |
Rattus norvegicus |
Hedgehog signaling pathway |
Rattus norvegicus |
Cardiovascular signaling |
Rattus norvegicus |
Flower development |
Arabidopsis thaliana |
Long-day flowering time pathway |
Arabidopsis thaliana |
Abscisic acid biosynthesis |
Arabidopsis thaliana |
Triacylglycerol biosynthesis |
Arabidopsis thaliana |
Cholesterol metabolism |
Rattus norvegicus |
ATM signaling pathway |
Rattus norvegicus |
p53 signal pathway |
Rattus norvegicus |
IL-9 signaling pathway |
Rattus norvegicus |
Heart development |
Homo sapiens |
Proteasome degradation |
Homo sapiens |
Thyroid stimulating hormone (TSH) signaling pathway |
Homo sapiens |
Pathogenic Escherichia coli infection |
Homo sapiens |
Heroin metabolism |
Homo sapiens |
Initiation of transcription and translation elongation at the HIV-1 LTR |
Homo sapiens |
Amino acid metabolism |
Homo sapiens |
miRNA regulation of prostate cancer signaling pathways |
Homo sapiens |
Ethanol effects on histone modifications |
Homo sapiens |
Acrylamide biotransformation and exposure biomarkers |
Homo sapiens |
Extracellular vesicles in the crosstalk of cardiac cells |
Homo sapiens |
Bile acids synthesis and enterohepatic circulation |
Homo sapiens |
Oxidation by cytochrome P450 |
Homo sapiens |
Platelet-mediated interactions with vascular and circulating cells |
Homo sapiens |
Genes related to primary cilium development (based on CRISPR) |
Homo sapiens |
Cytosolic DNA-sensing pathway |
Homo sapiens |
Small cell lung cancer |
Homo sapiens |
DNA replication |
Homo sapiens |
Endoplasmic reticulum stress response in coronavirus infection |
Homo sapiens |
IL-2 signaling pathway |
Homo sapiens |
Interactions of natural killer cells in pancreatic cancer |
Homo sapiens |
DNA adduct formation leading to kidney failure |
Homo sapiens |
NRXN1 deletion syndrome |
Homo sapiens |
Translation factors |
Homo sapiens |
TP53 network |
Homo sapiens |
Leptin signaling pathway |
Homo sapiens |
Interleukin-11 signaling pathway |
Homo sapiens |
miRNA biogenesis |
Homo sapiens |
Glycerophospholipid biosynthetic pathway |
Homo sapiens |
Farnesoid X receptor pathway |
Homo sapiens |
Nuclear receptors meta-pathway |
Homo sapiens |
Overview of nanoparticle effects |
Homo sapiens |
Imatinib and chronic myeloid leukemia |
Homo sapiens |
Hematopoietic stem cell gene regulation by GABP alpha/beta complex |
Homo sapiens |
lncRNA-mediated mechanisms of therapeutic resistance |
Homo sapiens |
Tgif disruption of Shh signaling |
Homo sapiens |
TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition |
Homo sapiens |
GPR40 pathway |
Homo sapiens |
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity |
Homo sapiens |
Ebola virus infection in host |
Homo sapiens |
lncRNA in canonical Wnt signaling and colorectal cancer |
Homo sapiens |
Hippo-YAP signaling |
Homo sapiens |
Leukocyte-intrinsic Hippo pathway functions |
Homo sapiens |
Canonical NF-kB pathway |
Homo sapiens |
Metabolism of alpha-linolenic acid |
Homo sapiens |
Sphingolipid metabolism: integrated pathway |
Homo sapiens |
HIPK2 in kidney fibrosis |
Homo sapiens |
Familial partial lipodystrophy |
Homo sapiens |
Familial hyperlipidemia type 1 |
Homo sapiens |
N-glycan biosynthesis |
Homo sapiens |
2q37 copy number variation syndrome |
Homo sapiens |
LDL- influence on CD14 and TLR4 |
Homo sapiens |
Cholesterol biosynthesis pathway in hepatocytes |
Homo sapiens |
Pancreatic cancer subtypes |
Homo sapiens |
Oxidative phosphorylation |
Homo sapiens |
Catalytic cycle of mammalian flavin-containing monooxygenases (FMOs) |
Homo sapiens |
Phase I biotransformations, non-P450 |
Bos taurus |
IL-9 signaling pathway |
Mus musculus |
Vitamin D metabolism |
Homo sapiens |
Angiogenesis |
Homo sapiens |
Sterol regulatory element-binding proteins (SREBP) signaling |
Homo sapiens |
Focal adhesion: PI3K-Akt-mTOR signaling pathway |
Mus musculus |
MECP2 and associated Rett syndrome |
Homo sapiens |
RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis |
Homo sapiens |
Pyrimidine metabolism and related diseases |
Homo sapiens |
Vitamin B12 disorders |
Homo sapiens |
MTHFR deficiency |
Homo sapiens |
Glycosylation and related congenital defects |
Homo sapiens |
Aerobic glycolysis |
Homo sapiens |
Mitochondrial complex I inhibition leading to chemical-induced Fanconi syndrome |
Homo sapiens |
Ethylmalonic encephalopathy |
Homo sapiens |
Glyoxylate metabolism |
Homo sapiens |
Osteoarthritic chondrocyte hypertrophy |
Homo sapiens |
Cell lineage map for neuronal differentiation |
Homo sapiens |
ADHD and autism (ASD) linked metabolic pathways and SNP |
Homo sapiens |
DNA damage response |
Homo sapiens |
Alzheimer's disease and miRNA effects |
Homo sapiens |
Parkinson's disease pathway |
Homo sapiens |
ATM signaling pathway |
Homo sapiens |
miRNA targets in ECM and membrane receptors |
Homo sapiens |
EV release from cardiac cells and their functional effects |
Homo sapiens |
Ovarian infertility |
Homo sapiens |
GABA metabolism (aka GHB) |
Homo sapiens |
GPCRs, class C metabotropic glutamate, pheromone |
Rattus norvegicus |
FABP4 in ovarian cancer |
Homo sapiens |
Suppression of HMGB1-mediated inflammation by THBD |
Homo sapiens |
16p11.2 distal deletion syndrome |
Homo sapiens |
Steroid biosynthesis |
Homo sapiens |
Proline and hydroxyproline pathways |
Homo sapiens |
Cohesin complex - Cornelia de Lange syndrome |
Homo sapiens |
NIPBL role in DNA damage - Cornelia de Lange syndrome |
Homo sapiens |
NRP1-triggered signaling pathways in pancreatic cancer |
Homo sapiens |
Cell interactions of the pancreatic cancer microenvironment |
Homo sapiens |
Type II diabetes mellitus |
Homo sapiens |
Effects of nitric oxide |
Homo sapiens |
Mammary gland development pathway - Puberty (Stage 2 of 4) |
Homo sapiens |
ATM signaling in development and disease |
Homo sapiens |
OSX and miRNAs in tooth development |
Homo sapiens |
Inflammatory response pathway |
Rattus norvegicus |
Wnt signaling in kidney disease |
Homo sapiens |
Vitamin B6-dependent and responsive disorders |
Homo sapiens |
Acute viral myocarditis |
Homo sapiens |
Envelope proteins and their potential roles in EDMD physiopathology |
Homo sapiens |
Oxysterols derived from cholesterol |
Homo sapiens |
Nephrotic syndrome |
Homo sapiens |
Kisspeptin/kisspeptin receptor system in the ovary |
Homo sapiens |
p53 transcriptional gene network |
Homo sapiens |
Hypoxia-dependent differentiation of myoblasts |
Mus musculus |
Glycine metabolism, including IMDs |
Homo sapiens |
Riboflavin and CoQ disorders |
Homo sapiens |
7-oxo-C and 7-beta-HC pathways |
Homo sapiens |
Creatine pathway |
Homo sapiens |
Glucose metabolism in triple-negative breast cancer cells |
Homo sapiens |
GLP-1 from intestine and pancreas and role in glucose homeostasis |
Homo sapiens |